<SEC-DOCUMENT>0001666071-21-000035.txt : 20210305
<SEC-HEADER>0001666071-21-000035.hdr.sgml : 20210305
<ACCEPTANCE-DATETIME>20210305162149
ACCESSION NUMBER:		0001666071-21-000035
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20210302
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210305
DATE AS OF CHANGE:		20210305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cardlytics, Inc.
		CENTRAL INDEX KEY:			0001666071
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		IRS NUMBER:				263039436
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38386
		FILM NUMBER:		21718740

	BUSINESS ADDRESS:	
		STREET 1:		675 PONCE DE LEON AVENUE, NE
		STREET 2:		SUITE 6000
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30308
		BUSINESS PHONE:		888-798-5802

	MAIL ADDRESS:	
		STREET 1:		675 PONCE DE LEON AVENUE, NE
		STREET 2:		SUITE 6000
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30308
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cdlx-20210302.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:b7576783-1552-4e70-af69-63513d6bcbf1,g:4bbd941e-7b64-4c72-8c4c-f13d72de5131,d:6e903e13aad54e90bdb576480eb3d6e4--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cdlx="http://www.cardlytics.com/20210302" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cdlx-20210302</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i630c736911e24f078cbdfd685d0b516c_D20200930-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF80L2ZyYWc6NWEzMDU5N2U4YTgxNGQ0MDlhN2FkNzFiNDVkOWYyNDUvdGFibGU6OGY4NTU5NTUzNjY1NGU0NGJmMTI2MjU1N2E3NjgxY2MvdGFibGVyYW5nZTo4Zjg1NTk1NTM2NjU0ZTQ0YmYxMjYyNTU3YTc2ODFjY18yLTEtMS0xLTA_234192d7-8855-41dc-b741-c3e63bf2ef23">0001666071</ix:nonNumeric><ix:nonNumeric contextRef="i630c736911e24f078cbdfd685d0b516c_D20200930-20200930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF80L2ZyYWc6NWEzMDU5N2U4YTgxNGQ0MDlhN2FkNzFiNDVkOWYyNDUvdGFibGU6OGY4NTU5NTUzNjY1NGU0NGJmMTI2MjU1N2E3NjgxY2MvdGFibGVyYW5nZTo4Zjg1NTk1NTM2NjU0ZTQ0YmYxMjYyNTU3YTc2ODFjY181LTEtMS0xLTA_974c8b9a-5c5f-4252-89e6-ae10519c4ce8">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cdlx-20210302.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001666071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-02</xbrli:startDate><xbrli:endDate>2021-03-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i630c736911e24f078cbdfd685d0b516c_D20200930-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001666071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-30</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6e903e13aad54e90bdb576480eb3d6e4_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGV4dHJlZ2lvbjo3NDM5ZGRlZjdlODM0NGRkYTcwZjQzZTcxNGI5YzllYl8xMDg5_3adfd1b1-cd04-419f-a665-0585ec65015e">8-K</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGV4dHJlZ2lvbjo3NDM5ZGRlZjdlODM0NGRkYTcwZjQzZTcxNGI5YzllYl8yMjk_e06ad081-3fa3-42b1-af5a-7996cd47ce5d">March 2, 2021</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><img src="cdlx-20210302_g1.jpg" alt="cdlx-20210302_g1.jpg" style="height:58px;margin-bottom:5pt;vertical-align:text-bottom;width:265px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGV4dHJlZ2lvbjo3NDM5ZGRlZjdlODM0NGRkYTcwZjQzZTcxNGI5YzllYl8xMDg3_cf73f3f6-b822-4194-8325-67ce6b4ab41c">CARDLYTICS,&#160;INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:40.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18wLTAtMS0xLTA_10af08e1-0a93-4eb0-862d-e3ce7c617ef3">Delaware</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18wLTEtMS0xLTA_5626b514-0809-482a-8e39-d4b2f590d37e">001-38386</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18wLTMtMS0xLTA_3c0a6f23-ed7f-463b-b2b1-65907552b9c0">26-3039436</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18yLTAtMS0xLTA_2e5bac9d-25a1-418b-9b7c-eaba1c876f83">675 Ponce de Leon Avenue NE, Suite 6000</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18yLTEtMS0xLTA_3ea23e9a-bc09-41a2-a731-b69c5209f9eb">Atlanta</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18yLTItMS0xLTA_61848329-4bcb-4279-8605-e15c08e1c62a">Georgia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18yLTMtMS0xLTA_a9f45296-0ca5-480b-9cde-898d53fd5382">30308</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices, including zip code)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN180LTEtMS0xLTA_d0bf0a01-b450-4398-be4c-aa087908fba5">(888)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN180LTItMS0xLTA_f04edf44-630c-45cc-8e87-b98ad04c0d1d">798-5802</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Registrant's telephone, including area code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6M2IxM2YxMDViYzUyNDE3MDkyY2UzNGQ5MTM5ODQzMTAvdGFibGVyYW5nZTozYjEzZjEwNWJjNTI0MTcwOTJjZTM0ZDkxMzk4NDMxMF8wLTAtMS0xLTA_40d3bef0-3faf-4d80-b5e2-ea9399fd2f82">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6M2IxM2YxMDViYzUyNDE3MDkyY2UzNGQ5MTM5ODQzMTAvdGFibGVyYW5nZTozYjEzZjEwNWJjNTI0MTcwOTJjZTM0ZDkxMzk4NDMxMF8xLTAtMS0xLTA_3a1d4cd6-f3df-40cd-a8e2-062674fa6b5e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6M2IxM2YxMDViYzUyNDE3MDkyY2UzNGQ5MTM5ODQzMTAvdGFibGVyYW5nZTozYjEzZjEwNWJjNTI0MTcwOTJjZTM0ZDkxMzk4NDMxMF8yLTAtMS0xLTA_904c7fd1-e9f9-4323-9a11-908003699584">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6M2IxM2YxMDViYzUyNDE3MDkyY2UzNGQ5MTM5ODQzMTAvdGFibGVyYW5nZTozYjEzZjEwNWJjNTI0MTcwOTJjZTM0ZDkxMzk4NDMxMF8zLTAtMS0xLTA_435a6cba-40f6-45a0-9f1f-90f47525f037">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="cdlx:Titleof12bSecurity" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6NmI1NzI3MWYwMTlmNGNjOWJhNjQwZjEyMzEzZDhjNjMvdGFibGVyYW5nZTo2YjU3MjcxZjAxOWY0Y2M5YmE2NDBmMTIzMTNkOGM2M18xLTAtMS0xLTA_928bcb74-7bff-40d3-a7dd-029154ecd7fb">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6NmI1NzI3MWYwMTlmNGNjOWJhNjQwZjEyMzEzZDhjNjMvdGFibGVyYW5nZTo2YjU3MjcxZjAxOWY0Y2M5YmE2NDBmMTIzMTNkOGM2M18xLTEtMS0xLTA_799ef44c-7d06-4f80-a947-4fa6d4315ac8">CDLX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6NmI1NzI3MWYwMTlmNGNjOWJhNjQwZjEyMzEzZDhjNjMvdGFibGVyYW5nZTo2YjU3MjcxZjAxOWY0Y2M5YmE2NDBmMTIzMTNkOGM2M18xLTItMS0xLTA_ed4d55d8-118f-4293-8fc2-d130c3d723ba">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.619%"><tr><td style="width:1.0%"></td><td style="width:88.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6NTBmYTNiY2Q3OWViNGU2YWFiMWYwOGU1MDYyODU1M2QvdGFibGVyYW5nZTo1MGZhM2JjZDc5ZWI0ZTZhYWIxZjA4ZTUwNjI4NTUzZF8wLTEtMS0xLTA_66439c5f-49da-4588-a56e-f7e1e3ad474d">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i6e903e13aad54e90bdb576480eb3d6e4_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8.01&#160;&#160;&#160;&#160;OTHER EVENTS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 2, 2021, Cardlytics, Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the underwriters (the &#8220;Underwriters&#8221;), relating to the issuance and sale of 3,850,000 shares of the Company&#8217;s common stock by the Company. The price to the public in this offering is $130.00 per share, and the Underwriters have agreed to purchase the shares from the Company pursuant to the Underwriting Agreement at a price of $125.775 per share. The net proceeds to the Company from this offering are expected to be approximately $483.7 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering closed on March 5, 2021. In addition, under the terms of the Underwriting Agreement, the Company has granted the Underwriters an option, exercisable for 30 days, to purchase up to an additional 577,500 shares of its common stock from the Company on the same terms and conditions. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by such parties. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The offering is being made pursuant to the Company&#8217;s effective registration statement on Form S-3 (Registration Statement No. 333-253697) previously filed with the Securities and Exchange Commission and a related prospectus and prospectus supplement. The foregoing is only a brief description of the terms of the Underwriting Agreement, does not purport to be a complete statement of the rights and obligations of the parties under the Underwriting Agreement and the transactions contemplated thereby, and is qualified in its entirety by reference to the Underwriting Agreement that is filed as Exhibit 1.1 hereto. A copy of the opinion of Cooley LLP relating to the legality of the issuance and sale of the shares in the offering is attached as Exhibit 5.1 hereto. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 1, 2021, the Company issued a press release announcing the offering. On March 2, 2021, the Company issued a press release announcing that it had priced the offering. Copies of the press releases are filed herewith as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Forward-Looking Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This report includes information that constitutes &#8220;forward-looking statements&#8221; made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risk and uncertainties. The words &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will&#8221; and similar expressions are intended to identify forward-looking statements. Forward-looking statements are based on Cardlytics&#8217; current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include risks related to the satisfaction of closing conditions and other factors that are set forth in Cardlytics&#8217; filings with the SEC, including Cardlytics&#8217; Annual Report on Form 10-K for the year ended December 31, 2020 and other filings Cardlytics makes with the SEC from time to time, under the caption &#8220;Risk Factors.&#8221; The statements made in this report are based on information available to the Company as of the date of this report and the Company undertakes no obligation to update any of the forward-looking statements after the date of this report.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.01&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND EXHIBITS</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:6.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="cdlx_exx11xunderwritingxag.htm">Underwriting Agreement, dated March 2, 2021, by and among Cardlytics, Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a51cooleyllpopinion_2021x8k.htm">Opinion of Cooley, LLP</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a231cooleyllpconsent_2021x.htm">Consent of Cooley LLP (included in Exhibit 5.1).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cdlx_exx991x0301pressrelea.htm">Press Release, dated March 1, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cdlx_exx992x0302pressrelea.htm">Press Release, dated March 2, 2021</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i6e903e13aad54e90bdb576480eb3d6e4_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:14pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.235%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cardlytics, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 5, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Andrew Christiansen</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew Christiansen</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>cdlx_exx11xunderwritingxag.htm
<DESCRIPTION>EX-1.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6f3ff1d696734ec3b2ec377dd526c935_32"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CARDLYTICS, INC. </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">3,850,000 Shares of Common Stock </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Underwriting Agreement </font></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">March 2, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BofA Securities, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">J.P. Morgan Securities LLC </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As Representatives of the </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">several Underwriters listed </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in Schedule 1 hereto</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">c&#47;o BofA Securities, Inc. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">One Bryant Park </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">New York, NY 10036 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">c&#47;o J.P. Morgan Securities LLC </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">383 Madison Avenue </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">New York, New York 10179 </font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Ladies and Gentlemen&#58; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                Cardlytics, Inc., a Delaware corporation (the &#8220;Company&#8221;), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the &#8220;Underwriters&#8221;), for whom you are acting as representatives (the &#8220;Representatives&#8221;), an aggregate of 3,850,000 shares of Common Stock, par value $0.0001 per share, of the Company (the &#8220;Underwritten Shares&#8221;). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 577,500 shares of Common Stock of the Company (the &#8220;Option Shares&#8221;). The Underwritten Shares and the Option Shares are herein referred to as the &#8220;Shares.&#8221; The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the &#8220;Stock.&#8221; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                The Company hereby confirms its agreement with the several Underwriters concerning the purchase and sale of the Shares as follows&#58; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company has prepared and filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;Securities Act&#8221;), an &#8220;automatic shelf registration statement&#8221; as defined by Rule 405 of the Securities Act on Form S-3 (File No. 333-253697), including a prospectus, relating to the Shares. Such registration statement, as amended at the time it became effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the registration statement at the time of its effectiveness (&#8220;Rule 430 Information&#8221;), is referred to herein as the &#8220;Registration Statement&#8221;&#59; and as used herein, the term &#8220;Preliminary Prospectus&#8221; means each prospectus included in such registration statement (and any amendments thereto) before effectiveness, any prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at the time of its effectiveness that omits Rule 430 Information (the &#8220;Base Prospectus&#8221;), and the prospectus supplement thereto dated March 1, 2021 relating to the Shares, and the term &#8220;Prospectus&#8221; means the Base Prospectus and prospectus supplement in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Shares. Any reference in this underwriting agreement (this &#8220;Agreement&#8221;) to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the effective date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &#8220;amend&#8221;, &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;Exchange Act&#8221;) that are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                At or prior to the Applicable Time (as defined below), the Company had prepared the following information (collectively with the pricing information set forth on Annex A, the &#8220;Pricing Disclosure Package&#8221;)&#58; a Preliminary Prospectus dated March 1, 2021 and each &#8220;free-writing prospectus&#8221; (as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                &#8220;Applicable Time&#8221; means 5&#58;00 P.M., New York City time, on March 2, 2021. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Purchase of the Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. (a) The Company agrees to issue and sell the Underwritten Shares to the several Underwriters as provided in this Agreement, and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase at a price per share of $125.775 (the &#8220;Purchase Price&#8221;) from the Company the respective number of Underwritten Shares set forth opposite such Underwriter&#8217;s name in Schedule 1 hereto.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                In addition, the Company agrees to issue and sell the Option Shares to the several Underwriters as provided in this Agreement, and the Underwriters, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase, severally and not jointly, from the Company the Option Shares at the Purchase Price less an amount per share equal to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares. If any Option Shares are to be purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares which bears the same ratio to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such Underwriter in Schedule 1 hereto (or such number increased as set forth in Section 10 hereof) bears to the aggregate number of Underwritten Shares being purchased from the Company by the several Underwriters, subject, however, to such adjustments to eliminate any fractional Shares as the Representatives in their sole discretion shall make. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                The Underwriters may exercise the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the thirtieth day following the date of the Prospectus, by written notice from the Representatives to the Company. Such notice shall set forth the aggregate number of Option Shares as to which the option is being exercised and the date and time when the Option Shares are to be delivered and paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than the tenth full business day (as hereinafter defined) after the date of such notice (unless such time and date are postponed in accordance with the provisions of Section 10 hereof). Any such notice shall be given at least two business days prior to the date and time of delivery specified therein. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (b) The Company understands that the Underwriters intend to make a public offering of the Shares, and initially to offer the Shares on the terms set forth in the Pricing Disclosure Package and the Prospectus. The Company acknowledges and agrees that the Underwriters may offer and sell Shares to or through any affiliate of an Underwriter. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (c) Payment for the Shares shall be made by wire transfer in immediately available funds to the accounts specified by the Company to the Representatives in the case of the Underwritten Shares, at the offices of Latham &#38; Watkins LLP, counsel for the Underwriters, at 140 Scott Drive, Menlo Park, California 94025 at 10&#58;00 A.M. New York City time on March 5, 2021, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing or, in the case of the Option Shares, on the date and at the time and place specified by the Representatives in the written notice of the Underwriters&#8217; election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as the &#8220;Closing Date,&#8221; and the time and date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as the &#8220;Additional Closing Date.&#8221;  </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                Payment for the Shares to be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery to the Representatives for the respective accounts of the several Underwriters of the Shares to be purchased on such date, or the Additional Closing Date, as the case may be, with any transfer taxes payable in connection with the sale of such Shares duly paid by the Company, as applicable. Delivery of the Shares shall be made through the facilities of The Depository Trust Company (&#8220;DTC&#8221;) unless the Representatives shall otherwise instruct. The Shares shall be delivered to the Underwriters, through the facilities of DTC, in book-entry form in such names and in such denominations as the Underwriters shall specify no later than the second business day preceding the time at which such payment and delivery is made. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (d) The Company acknowledges and agrees that the Representatives and the other Underwriters are acting solely in the capacity of an arm&#8217;s length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally, neither the Representatives nor any other Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and neither the Representatives nor any other Underwriter shall have any responsibility or liability to the Company with respect thereto. Any review by the Representatives and the other Underwriters of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Representatives and the other Underwriters and shall not be on behalf of the Company. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company represents and warrants to each Underwriter that&#58; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Preliminary Prospectus.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material respects with the Securities Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pricing Disclosure Package</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Pricing Disclosure Package, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof. No statement of material fact included in the Prospectus has been omitted from the Pricing Disclosure Package and no statement of material fact included in the Pricing Disclosure Package that is required to be included in the Prospectus has been omitted therefrom. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Issuer Free Writing Prospectus. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &#8220;written communication&#8221; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares (each such communication by the Company or its agents and representatives (other than a communication referred to in clause (i) below) an &#8220;Issuer Free Writing Prospectus&#8221;) other than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex A hereto, each electronic road show and any other written communications approved in writing in advance by the Representatives. Each such Issuer Free Writing Prospectus complies in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433 under the Securities Act) filed in accordance with the Securities Act (to the extent required thereby) and does not conflict with the information contained in the Registration Statement or the Pricing Disclosure Package, and, when taken together with the Preliminary Prospectus accompanying, or delivered prior to delivery of, such Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that the Company makes no representation or warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus or Preliminary Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Issuer Free Writing Prospectus or Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Testing-the-Waters Materials. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company (i) has not alone engaged in any Testing-the-Waters Communications other than Testing-the-Waters Communications with the consent of the Representatives with entities that the Company reasonably believed to be qualified institutional buyers or accredited investors within the meaning of Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act and otherwise in compliance with the requirements of Rule 163B under the Securities Act and (ii) has not authorized anyone to engage in Testing-the-Waters Communications. The Company has not distributed or approved for distribution any Written Testing-the-Waters Communications other than those listed on Annex B hereto. &#8220;Testing-the-Waters Communication&#8221; means any oral or written communication with potential investors undertaken in reliance on Rule 163B of the Securities Act. &#8220;Written Testing-the-Waters Communication&#8221; means any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405 under the Securities Act. Any individual Written Testing-the-Waters Communication did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Registration Statement and Prospectus.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Registration Statement is an &#8220;automatic shelf registration statement&#8221; as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof&#59; and no notice of objection of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued by the Commission, and no proceeding for that purpose or pursuant to Section 8A of the Securities Act against the Company or related to the offering of the Shares has been initiated or, to the knowledge of the Company, threatened by the Commission&#59; as of the applicable effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement and any such post-effective amendment complied and will comply in all material respects with the Securities Act, and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading. As of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the Additional Closing Date, as the case may be, the Prospectus will comply in all material respects with the Securities Act and will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement and the Prospectus and any amendment or supplement thereto, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section 7(b) hereof. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Incorporated Documents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The documents incorporated by reference in the Registration Statement, the Prospectus and the Pricing Disclosure Package, when they were filed with the Commission conformed in all material respects to the requirements of the Exchange Act, and none of such documents contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading&#59; and any further documents so filed and incorporated by reference in the Registration Statement, the Prospectus or the Pricing Disclosure Package, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Statements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The financial statements (including the related notes thereto) of the Company and its consolidated subsidiaries included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus present fairly, in all material respects, the financial position of the Company and its consolidated subsidiaries at the dates indicated and the statement of operations, stockholders&#8217; equity and cash flows of the Company and its consolidated subsidiaries for the periods specified&#59; said financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) applied on a consistent basis throughout the periods involved, except in the case of unaudited, interim financial statements, subject to normal year end audit adjustments and the exclusion of certain footnotes as permitted by the applicable rules of the Commission. The selected financial data and the summary financial information included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus present fairly, in all material respects, the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included therein. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (h) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Material Adverse Change in Business.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Except as otherwise stated therein, since the respective dates as of which information is given in the Registration Statement, the Pricing Disclosure Package or the Prospectus, (A) there has been no material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business (a &#8220;Material Adverse Effect&#8221;), (B) there have been no transactions entered into by the Company or any of its subsidiaries, other than those in the ordinary course of business, which are material with respect to the Company and its subsidiaries considered as one enterprise, and (D) there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Good Standing of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware and has corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and to enter into and perform its obligations under this Agreement&#59; and the Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction (to the extent the concept of &#8220;good standing&#8221; is applicable in each such jurisdiction) in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would not reasonably be expected to result in a Material Adverse Effect. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (j) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Good Standing of Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Each &#8220;significant subsidiary&#8221; of the Company (as such term is defined in Rule 1-02 of Regulation S-X) (each, a &#8220;Subsidiary&#8221; and, collectively, the &#8220;Subsidiaries&#8221;) has been duly organized and is validly existing in good standing under the laws of the jurisdiction of its incorporation or organization (to the extent the concept of &#8220;good standing&#8221; is applicable in each such jurisdiction), has corporate or similar power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification is required (to the extent the concepts of &#8220;qualification to transact business&#8221; and &#8220;good standing&#8221; are applicable in each such jurisdiction), whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to so qualify or to be in good standing would not reasonably be expected to result in a Material Adverse Effect. Except as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, all of the issued and outstanding capital stock or other equity interests of each Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable (to the extent such concepts are applicable in each such jurisdiction) and is owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity. None of the outstanding shares of capital stock or similar equity interests of any Subsidiary were issued in violation of the preemptive or similar rights of any securityholder of such Subsidiary. The only subsidiaries of the Company are (A) the subsidiaries listed on Exhibit 21.1 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Commission on March 1, 2021, and (B) certain other subsidiaries which, considered in the aggregate as a single subsidiary, do not constitute a &#8220;significant subsidiary&#8221; as defined in Rule 1-02 of Regulation S-X.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (k) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Capitalization.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The authorized, issued and outstanding shares of capital stock of the Company as of the Applicable Time are as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus in the column entitled &#8220;Actual&#8221; under the caption &#8220;Capitalization&#8221; (except for subsequent issuances, if any, pursuant to this Agreement, pursuant to reservations, agreements or employee benefit or equity incentive plans referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus or pursuant to the exercise of convertible securities or options referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus). The outstanding shares of capital stock of the Company as of the Applicable Time have been duly authorized and validly issued and are fully paid and non-assessable. None of the outstanding shares of capital stock of the Company as of the Applicable Time were issued in violation of the preemptive or other similar rights of any securityholder of the Company. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (l) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Authorization of Agreement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Agreement has been duly authorized, executed and delivered by the Company. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (m) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Authorization and Description of the Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Shares to be purchased by the Underwriters from the Company have been duly authorized for issuance and sale to the Underwriters pursuant to this Agreement and, when issued and delivered by the Company pursuant to this Agreement against payment of the consideration set forth herein, will be validly issued and fully paid and non-assessable&#59; and the issuance of the Shares is not subject to the preemptive or other similar rights of any securityholder of the Company, except as have been duly and validly waived in writing as of the date of this Agreement. The Common Stock conforms, in all material respects, to all statements relating thereto contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus and such descriptions conform, in all material respects, to the rights set forth in the instruments defining the same. No holder of Shares will be subject to personal liability solely by reason of being such a holder. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (n) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Absence of Violations, Defaults and Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Neither the Company nor any Subsidiary is (A) in violation of its charter, by-laws or similar organizational document, (B) in default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which it is a party or by which it is bound or to which any of its assets is subject (collectively, &#8220;Agreements and Instruments&#8221;), except for such defaults that would not, singly or in the aggregate, result in a Material Adverse Effect, or (C) in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency having jurisdiction over it or any of it properties, assets or operations (each, a &#8220;Governmental Entity&#8221;), except for such violations that would not, singly or in the aggregate, result in a Material Adverse Effect. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated herein and in the Registration Statement, the Pricing Disclosure Package and the Prospectus (including the issuance and sale of the Shares and the use of the proceeds from the sale of the Shares as described therein under the caption &#8220;Use of Proceeds&#8221;) and compliance by the Company with its obligations hereunder have been duly authorized by all necessary corporate action and do not and will not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Company or any subsidiary pursuant to, the Agreements and Instruments (except for such conflicts, breaches, defaults or Repayment Events or liens, charges or encumbrances that would not, singly or in the aggregate, result in a Material Adverse Effect), nor will such action result in any violation of the provisions of the charter, by-laws or similar organizational document of the Company or any of its subsidiaries or any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity. As used herein, a &#8220;Repayment Event&#8221; means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#8217;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (o) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Absence of Labor Dispute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. No labor dispute with the employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or any subsidiary&#8217;s principal suppliers, manufacturers, customers or contractors, which, in either case, would reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (p) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Absence of Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there is no action, suit, proceeding, inquiry or investigation before or brought by any Governmental Entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries, which would reasonably be expected to result in a Material Adverse Effect, or which would reasonably be expected to materially and adversely affect their respective properties or assets or the consummation of the transactions contemplated in this Agreement or the performance by the Company of its obligations hereunder&#59; and the aggregate of all pending legal or governmental proceedings to which the Company or any such subsidiary is a party or of which any of their respective properties or assets is the subject which are not described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, including ordinary routine litigation incidental to the business, would not reasonably be expected to result in a Material Adverse Effect. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (q) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accuracy of Exhibits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. There are no contracts or documents which are required under the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus or to be filed as exhibits to the Registration Statement which have not been so described and filed as required. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (r) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Absence of Further Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. No filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any Governmental Entity is necessary or required for the performance by the Company of its obligations hereunder, in connection with the offering, issuance or sale of the Shares hereunder or the consummation of the transactions contemplated by this Agreement, except (A) such as have been already obtained or as may be required under the Securities Act, the rules of the Nasdaq Stock Market LLC, state securities laws or the rules of the Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) and (B) such as have been obtained under the laws and regulations of jurisdictions outside the United States in which the Shares were offered or (C) such as which the failure to obtain would not, singly or in the aggregate, materially impair the power or ability of the Company to perform its obligations under this Agreement or consummate the transactions contemplated thereby. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (s) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Possession of Licenses and Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company and its subsidiaries possess such permits, licenses, approvals, consents and other authorizations (collectively, &#8220;Governmental Licenses&#8221;) issued by the appropriate Governmental Entities necessary to conduct the business now operated by them, except where the failure so to possess would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect. The Company and its subsidiaries are in compliance with the terms and conditions of all Governmental Licenses, except where the failure so to comply would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect. All of the Governmental Licenses are valid and in full force and effect, except when the invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of any Governmental Licenses which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to result in a Material Adverse Effect. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (t) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Title to Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company and its subsidiaries have good and marketable title to all real property owned by them and good title to all other properties owned by them, in each case, free and clear of all mortgages, pledges, liens, security interests, claims, restrictions or encumbrances of any kind except such as (A) are described in the Registration Statement, the Pricing Disclosure Package and the Prospectus or (B) do not, singly or in the aggregate, materially adversely affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company or any of its subsidiaries&#59; and all of the leases and subleases material to the business of the Company and its subsidiaries, considered as one enterprise, and under which the Company or any of its subsidiaries holds properties described in the Registration Statement, the Pricing Disclosure Package or the Prospectus, are in full force and effect, and neither the Company nor any such subsidiary has any notice of any material claim of any sort that has been asserted by anyone adverse to the rights of the Company or any subsidiary under any of the leases or subleases mentioned above, or affecting or questioning the rights of the Company or such subsidiary to the continued possession of the leased or subleased premises under any such lease or sublease, except to the extent that where such failure to be in effect or such claim or adverse effect on the Company&#8217;s or any subsidiary&#8217;s rights would not reasonably be expected to result in a Material Adverse Effect. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (u) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Possession of Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company and its subsidiaries own or possess, or can acquire on reasonable terms, adequate patents, patent rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented and&#47;or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, trade names or other intellectual property (collectively, &#8220;Intellectual Property&#8221;) necessary to carry on the businesses now operated by them as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and neither the Company nor any of its subsidiaries has received any notice or is otherwise aware of any infringement of or conflict with asserted rights of others with respect to any Intellectual Property or of any facts or circumstances which would render any Intellectual Property invalid or inadequate to protect the interest of the Company or any of its subsidiaries therein, and which infringement or conflict (if the subject of any unfavorable decision, ruling or finding) or invalidity or inadequacy, singly or in the aggregate, would result in a Material Adverse Effect. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (v) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus or would not, singly or in the aggregate, result in a Material Adverse Effect, (A) neither the Company nor any of its subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively, &#8220;Hazardous Materials&#8221;) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, &#8220;Environmental Laws&#8221;), (B) the Company and its subsidiaries have all permits, authorizations and approvals required for their operations under any applicable Environmental Laws and are each in compliance with their requirements, (C) there are no pending or, to the Company&#8217;s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigations or proceedings relating to any Environmental Law against the Company or any of its subsidiaries and (D) to the Company&#8217;s knowledge, there are no events or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or proceeding by any private party or Governmental Entity, against or affecting the Company or any of its subsidiaries relating to Hazardous Materials or any Environmental Laws. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (w) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Independent Accountants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Deloitte &#38; Touche LLP, who has certified certain financial statements of the Company and its subsidiaries, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (x) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Undisclosed Relationships.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required by the Securities Act to be described in each of the Registration Statement and the Prospectus and that is not so described in such documents and in the Pricing Disclosure Package. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (y) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company is not required, and upon the issuance and sale of the Shares as herein contemplated and the application of the net proceeds therefrom as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus will not be required, to register as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (zz) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Payment of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. All United States federal income tax returns of the Company and its subsidiaries required by law to be filed by them (taking into account any timely requested extensions thereof) have been filed and all United States federal income taxes shown by such returns or otherwise assessed, which are due and payable, have been paid, except assessments against which appeals have been or will be promptly taken and as to which adequate reserves have been provided, and except insofar as the failure to file such returns and pay such taxes would not reasonably be expected to result in a Material Adverse Effect. The United States federal income tax returns of the Company through the fiscal year ended December 31, 2019 have been settled and no assessment in connection therewith has been made against the Company. The Company and its subsidiaries have filed all other tax returns that are required to have been filed by them pursuant to applicable foreign, state, local or other law and has paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company and its subsidiaries, except for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been established by the Company, and except insofar as the failure to file such returns and pay such taxes would not reasonably be expected to result in a Material Adverse Effect. The charges, accruals and reserves on the books of the Company in respect of any income and corporation tax liability for any years not finally determined are adequate to meet any assessments or re-assessments for additional income tax for any years not finally determined, except to the extent of any inadequacy that would not reasonably be expected to result in a Material Adverse Effect. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (aa) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company and its subsidiaries carry or are entitled to the benefits of insurance, with financially sound and reputable insurers, in such amounts and covering such risks as the Company believes is generally maintained by companies of established repute and comparable size engaged in the same or similar business, and all such insurance is in full force and effect. The Company has no reason to believe that it or any of its subsidiaries will not be able (A) to renew its existing insurance coverage as and when such policies expire or (B) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not reasonably be expected to result in a Material Adverse Effect. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (bb) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Absence of Manipulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Neither the Company nor any affiliate of the Company has taken, nor will the Company or any affiliate take, directly or indirectly, any action which is designed, or would be expected, to cause or result in, or which constitutes, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Shares or to result in a violation of Regulation M under the Exchange Act. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (cc) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Compliance with ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. (i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), for which the Company or any member of its &#8220;Controlled Group&#8221; (defined as any entity, whether or not incorporated, that is under common control with the Company within the meaning of Section 4001(a)(14) of ERISA or any entity that would be regarded as a single employer with the Company under Section 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)) would have any liability (each, a &#8220;Plan&#8221;) has been maintained in compliance, in all material respects, with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Code&#59; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect to any Plan, excluding transactions effected pursuant to a statutory or administrative exemption&#59; (iii) for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail, to satisfy the minimum funding standards (within the meaning of Section 302 of ERISA or Section 412 of the Code) applicable to such Plan&#59; (iv) no Plan is, or is reasonably expected to be, in &#8220;at risk status&#8221; (within the meaning of Section 303(i) of ERISA) and no Plan that is a &#8220;multiemployer plan&#8221; within the meaning of Section 4001(a)(3) of ERISA is in &#8220;endangered status&#8221; or &#8220;critical status&#8221; (within the meaning of Sections 304 and 305 of ERISA) (v) the fair market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan)&#59; (vi) no &#8220;reportable event&#8221; (within the meaning of Section 4043(c) of ERISA and the regulations promulgated thereunder) has occurred or is reasonably expected to occur&#59; (vii) each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified, and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification&#59; (viii) neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guaranty Corporation, in the ordinary course and without default) in respect of a Plan (including a &#8220;multiemployer plan&#8221; within the meaning of Section 4001(a)(3) of ERISA)&#59; and (ix) none of the following events has occurred or is reasonably likely to occur&#58; (A) a material increase in the aggregate amount of contributions required to be made to all Plans by the Company or its Controlled Group affiliates in the current fiscal year of the Company and its Controlled Group affiliates compared to the amount of such contributions made in the Company&#8217;s and its Controlled Group affiliates&#8217; most recently completed fiscal year&#59; or (B) a material increase in the Company and its subsidiaries&#8217; &#8220;accumulated post-retirement benefit obligations&#8221; (within the meaning of Accounting Standards Codification Topic 715-60) compared to the amount of such obligations in the Company and its subsidiaries&#8217; most recently completed fiscal year, except in each case with respect to the events or conditions set forth in (i) through (ix) hereof, as would not, individually or in the aggregate, have a Material Adverse Effect. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (dd) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Disclosure Controls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company and its subsidiaries maintain an effective system of &#8220;disclosure controls and procedures&#8221; (as defined in Rule 13a-15(e) of the Exchange Act) that complies with the requirements of the Exchange Act and that has been designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#8217;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding required disclosure. The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (ee) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Accounting Controls.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company and its subsidiaries maintain systems of &#8220;internal control over financial reporting&#8221; (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The Company and its subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations&#59; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability&#59; (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization&#59; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences and (v) interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Prospectus and the Pricing Disclosure Package fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto. Based on the Company&#8217;s most recent evaluation of its internal controls over financial reporting pursuant to Rule 13a-15(c) of the Exchange Act, except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no material weaknesses in the Company&#8217;s internal controls. The Company&#8217;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of&#58; (i) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which have adversely affected or are reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial information&#59; and (ii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal controls over financial reporting. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (ff) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">eXtensible Business Reporting Language</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly present the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (gg) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Privacy and Data Protection. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company (A) is in compliance, in all material respects, with all privacy and data protection laws and regulations applicable to the Company&#8217;s collection, handling, and storage of its customers&#8217; data and (B) has and is in compliance with policies and procedures that are reasonably designed to ensure the integrity and security of the data collected, handled or stored in connection with the operation of its business. The Company and Subsidiaries are in compliance, in all material respects, with applicable third party obligations relating to privacy and data protection imposed in writing on the Company and&#47;or Subsidiaries, as applicable. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (hh) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Unlawful Payments.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Neither the Company nor any of its subsidiaries, nor any director, officer or employee of the Company or any of its subsidiaries nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity&#59; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office&#59; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law&#59; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Compliance with Anti-Money Laundering Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#8220;Anti-Money Laundering Laws&#8221;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (jj) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Conflicts with Sanctions Laws. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Neither the Company nor any of its subsidiaries, directors, officers or employees, nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S. government (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#8220;OFAC&#8221;) or the U.S. Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council (&#8220;UNSC&#8221;), the European Union, Her Majesty&#8217;s Treasury (&#8220;HMT&#8221;) or other relevant sanctions authority (collectively, &#8220;Sanctions&#8221;), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or target of comprehensive territorial Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea and Syria (each, a &#8220;Sanctioned Country&#8221;)&#59; and the Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions. For the past five years, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (kk) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Sales of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In connection with any offer and sale of the Shares outside the United States, each preliminary prospectus, the Prospectus and any amendment or supplement thereto, at the time it was filed, complied and will comply in all material respects with any applicable laws or regulations of foreign jurisdictions in which the same is distributed. The Company has not offered, or caused the Representatives to offer, the Shares to any person with the specific intent to unlawfully influence (i) a customer or supplier of the Company or any of its affiliates to alter the customer&#8217;s or supplier&#8217;s level or type of business with any such entity or (ii) a trade journalist or publication to write or publish favorable information about the Company or any of its affiliates, or their respective businesses or products. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (ll) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lending Relationship. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company (i) does not have any material lending or other relationship with any banking or lending affiliate of any Underwriter and (ii) does not intend to use any of the proceeds from the sale of the Shares to repay any outstanding debt owed to any affiliate of any Underwriter. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (mm) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Statistical and Market-Related Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Any statistical and market-related data included in the Registration Statement, the Pricing Disclosure Package or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate and, to the extent required, the Company has obtained the written consent to the use of such data from such sources. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (nn) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Broker&#8217;s Fees.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or any Underwriter for a brokerage commission, finder&#8217;s fee or like payment in connection with the offering and sale of the Shares. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (oo) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Registration Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. There are no persons with registration rights or other similar rights to have any securities registered for sale pursuant to the Registration Statement or otherwise registered for sale or sold by the Company under the Securities Act pursuant to this Agreement, other than those rights that have been disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus and have been waived. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (pp) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Margin Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (qq) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Forward-Looking Statements.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (rr) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. There is and has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in their capacities as such, to comply in any material respect with any provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated therewith, including Section 402 related to loans and Sections 302 and 906 related to certifications. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (ss) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Status under the Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that the Company or any offering participant made a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Shares and at the date hereof, the Company was not and is not an &#8220;ineligible issuer,&#8221; as defined in Rule 405 under the Securities Act. The Company has paid the registration fee for this offering pursuant to Rule 456(b)(1) under the Securities Act or will pay such fee within the time period required by such rule (without giving effect to the proviso therein) and in any event prior to the Closing Date. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (tt) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Ratings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Neither the Company nor its subsidiaries have any debt securities or preferred stock that are rated by any &#8220;nationally recognized statistical rating organization&#8221; (as defined in Section 3(a)(62) of the Exchange Act). </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (uu) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Officer&#8217;s Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Any certificate signed by any officer of the Company or any of its subsidiaries delivered to the Representatives or to counsel for the Underwriters shall be deemed a representation and warranty by the Company to each Underwriter as to the matters covered thereby. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Further Agreements of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company covenants and agrees with each Underwriter that&#58; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Required Filings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities Act&#59; and the Company will use commercially reasonable efforts to file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Shares&#59; and the Company will use commercially reasonable efforts to furnish electronic copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City prior to 10&#58;00 A.M., New York City time, on the business day next succeeding the date of this Agreement in such quantities as the Representatives may reasonably request. The Company will pay the registration fee for this offering within the time period required by Rule 456(b)(1) under the Securities Act (without giving effect to the proviso therein) and in any event prior to the Closing Date.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Delivery of Copies.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company will deliver, without charge, (i) to the Representatives, five signed copies of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and documents incorporated by reference therein&#59; and (ii) to each Underwriter (A) a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) and (B) during the Prospectus Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein and each Issuer Free Writing Prospectus) as the Representatives may reasonably request. As used herein, the term &#8220;Prospectus Delivery Period&#8221; means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amendments or Supplements, Issuer Free Writing Prospectuses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Before making, preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure Package or the Prospectus, whether before or after the time that the Registration Statement becomes effective, the Company will furnish to the Representatives and counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the Representatives reasonably object in a timely manner. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Notice to the Representatives.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company will advise the Representatives promptly, and confirm such advice in writing, (i) when the Registration Statement has become effective&#59; (ii) when any amendment to the Registration Statement has been filed or becomes effective&#59; (iii) when any supplement to the Pricing Disclosure Package, the Prospectus, any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication or any amendment to the Prospectus has been filed or distributed&#59; (iv) of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information including, but not limited to, any request for information concerning any Testing-the-Waters Communication&#59; (v) of the issuance by the Commission or any other governmental or regulatory authority of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package, the Prospectus or any Written Testing-the-Waters Communication or the initiation or, to the knowledge of the Company, threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act&#59; (vi) of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure Package, any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package, any such Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication is delivered to a purchaser, not misleading&#59; (vii) of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act&#59; and (viii) of the receipt by the Company of any notice with respect to any suspension of the qualification of the Shares for offer and sale in any jurisdiction or the initiation or, to the knowledge of the Company, threatening of any proceeding for such purpose&#59; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or any Written Testing-the-Waters Communication or suspending any such qualification of the Shares and, if any such order is issued, will use its best efforts to obtain as soon as possible the withdrawal thereof. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Ongoing Compliance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (1) If during the Prospectus Delivery Period (i) any event or development shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply with law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate such amendments or supplements to the Prospectus (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Prospectus as so amended or supplemented (or any document to be filed with the Commission and incorporated by reference therein) will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with law and (2) if at any time prior to the Closing Date (i) any event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Pricing Disclosure Package to comply with law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the Pricing Disclosure Package (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Pricing Disclosure Package as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with law. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Blue Sky Compliance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company will use its reasonable best efforts, in cooperation with the Underwriters, to qualify the Shares for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Representatives may reasonably designate and to maintain such qualifications in effect so long as required to complete the distribution of the Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Earning Statement. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company will make generally available to its security holders and the Representatives as soon as practicable an earning statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &#8220;effective date&#8221; (as defined in Rule 158) of the Registration Statement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the Company will be deemed to have made available such earnings statement to the extent filed on the Commission&#8217;s Electronic Data Gathering, Analysis, and Retrieval system (&#8220;EDGAR&#8221;). </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (h) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Clear Market.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> From the date hereof through 60 days from the date of the Prospectus (the &#8220;Restricted Period&#8221;), the Company will not, without the prior written consent of the Representatives, (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or file any registration statement under the Securities Act with respect to any of the foregoing or (ii) enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Common Stock, whether any such swap or transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing sentence shall not apply to (A) the Shares to be sold hereunder, (B) any shares of Common Stock issued by the Company upon the exercise of an option or warrant or the settlement of restricted stock units or the conversion of a security outstanding on the date hereof and referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (C) any shares of Common Stock issued or options to purchase Common Stock or restricted stock units to be settled in Common Stock granted pursuant to employee benefit or equity incentive plans of the Company referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (D) any shares of Common Stock issued pursuant to any non-employee director stock plan or dividend reinvestment plan referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (E) the filing by the Company of a registration statement on Form S-8 or any successor form thereto with respect to the registration of securities to be offered under any employee benefit or equity incentive plans of the Company referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (F) any shares of Common Stock issued pursuant to that certain Agreement and Plan of Reorganization, by and among the Company, DOSH Holdings, Inc., BSPEARS MERGER SUB I, INC.,  and BSPEARS MERGER SUB II, LLC, dated as of February 26, 2021, including any shares of Common Stock issued upon exercise or vesting of any equity awards assumed or issued in connection with the acquisition, or (G) shares of Common Stock or other securities issued in connection with a transaction that includes a commercial relationship (including strategic alliances, commercial lending relationships, joint ventures and strategic acquisitions), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that (i) the aggregate number of shares issued pursuant to this clause (G) shall not exceed 7.0% of the total number of outstanding shares of Common Stock immediately following the issuance and sale of the Shares hereunder and (ii) the recipient of any such shares of Common Stock or securities issued pursuant to this clause (G) during the Restricted Period shall enter into an agreement substantially in the form of Exhibit A hereto. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Use of Proceeds.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company will apply the net proceeds from the sale of the Shares as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading &#8220;Use of Proceeds.&#8221; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (j) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Manipulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Neither the Company nor any affiliate of the Company will take, directly or indirectly, any action which is designed, or would reasonably be expected, to cause or result in, or which constitutes, the stabilization or manipulation of the price of any security of the Company. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (k) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Exchange Listing.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company will use its reasonable best efforts to list, subject to notice of issuance, the Shares on the Nasdaq Global Market (the &#8220;Nasdaq Market&#8221;). </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (l) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Reports.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> For a period of one year from the date hereof, the Company will furnish to the Representatives, as soon as they are available, copies of all reports or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial statements furnished to or filed with the Commission or any national securities exchange or automatic quotation system&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> the Company will be deemed to have furnished such reports and financial statements to the Representatives to the extent they are filed on EDGAR. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (m) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Record Retention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (n) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Shelf Renewal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. If immediately prior to the third anniversary (the &#8220;Renewal Deadline&#8221;) of the initial effective date of the Registration Statement, any of the Shares remain unsold by the Underwriters, the Company will, prior to the Renewal Deadline, file, if it has not already done so and is eligible to do so, a new automatic shelf registration statement relating to the Shares, in a form satisfactory to the Representatives. If the Company is not eligible to file an automatic shelf registration statement, the Company will, prior to the Renewal Deadline, if it has not already done so, file a new shelf registration statement relating to the Shares, in a form satisfactory to the Representatives, and will use its best efforts to cause such registration statement to be declared effective within 180 days after the Renewal Deadline. The Company will take all other action necessary or appropriate to permit the issuance and sale of the Shares to continue as contemplated in the expired registration statement relating to the Shares. References herein to the Registration Statement shall include such new automatic shelf registration statement or such new shelf registration statement, as the case may be. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Certain Agreements of the Underwriters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Each Underwriter hereby severally represents and agrees that&#58; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (a) It has not and will not use, authorize use of, refer to or participate in the planning for use of, any &#8220;free writing prospectus,&#8221; as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other than (i) a free writing prospectus that contains no &#8220;issuer information&#8221; (as defined in Rule 433(h)(2) under the Securities Act) that was not included (including through incorporation by reference) in the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section 3(c) or Section 5(c) above (including any electronic road show), or (iii) any free writing prospectus prepared by such underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i) or (iii), an &#8220;Underwriter Free Writing Prospectus&#8221;). </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (b) It has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final terms of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that Underwriters may use a term sheet substantially in the form of Annex C hereto without the consent of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that any Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company, prior to, or substantially concurrently with, the first use of such term sheet. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (c) It is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Conditions of Underwriters&#8217; Obligations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The obligation of each Underwriter to purchase the Underwritten Shares on the Closing Date or the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions&#58; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Registration Compliance&#59; No Stop Order.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding for such purpose pursuant to Rule 401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or, to the knowledge of the Company, threatened by the Commission&#59; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section 5(a) hereof&#59; and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representatives. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Representations and Warranties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The respective representations and warranties of the Company contained herein shall be true and correct on the date hereof and on and as of the Closing Date or the Additional Closing Date, as the case may be&#59; and the statements of the Company and its officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date, as the case may be. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Material Adverse Change.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> No event or condition of a type described in Section 3(h) hereof shall have occurred or shall exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the Representatives makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Officer&#8217;s Certificate.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, a certificate of the chief financial officer or chief accounting officer of the Company and one additional senior executive officer of the Company who is satisfactory to the Representatives (i) confirming that such officers have carefully reviewed the Registration Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations of the Company set forth in Sections 3(b) and 3(d) hereof are true and correct, (ii) confirming that the other representations and warranties of the Company in this Agreement are true and correct and that the Company has complied in all material respects with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be, and (iii) to the effect set forth in paragraphs (a), (b) and (c) above. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Comfort Letters.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                                (i) On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, Deloitte &#38; Touche LLP shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing statements and information of the type customarily included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with respect to the financial statements and certain financial information contained or incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus&#59; provided, that the letter delivered on the Closing Date or the Additional Closing Date, as the case may be, shall use a &#8220;cut-off&#8221; date no more than two business days prior to such Closing Date or such Additional Closing Date, as the case may be. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                                (ii) On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to the Representatives a certificate, dated the respective dates of delivery thereof and addressed to the Underwriters, of its chief financial officer with respect to certain financial data contained in the Pricing Disclosure Package and the Prospectus, providing &#8220;management comfort&#8221; with respect to such information, in form and substance reasonably satisfactory to the Representatives. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Opinion and 10b-5 Statement of Counsel for the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Cooley LLP, counsel for the Company, shall have furnished to the Representatives, at the request of the Company, their written opinion and 10b-5 statement, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Opinion and Negative Assurance Letter of Counsel for the Underwriters.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, an opinion and negative assurance letter, addressed to the Underwriters, of Latham &#38; Watkins LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (h) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">No Legal Impediment to Issuance and&#47;or Sale.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares by the Company&#59; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares by the Company. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Good Standing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, satisfactory evidence of the good standing of the Company and its subsidiaries in their respective jurisdictions of organization and their good standing in such other jurisdictions as the Representatives may reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (j) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Exchange Listing.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Shares to be delivered on the Closing Date or the Additional Closing Date, as the case may be, shall have been approved for listing on the Nasdaq Market, subject to official notice of issuance. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (k) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lock-up Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The &#8220;lock-up&#8221; agreements, each substantially in the form of Exhibit A hereto, between you and certain shareholders, officers and directors of the Company relating to sales and certain other dispositions of shares of Stock or certain other securities, delivered to you on or before the date hereof, shall be in full force and effect on the Closing Date or the Additional Closing Date, as the case may be. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (l) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Additional Documents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to the Representatives such further certificates and documents as the Representatives may reasonably request. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Indemnification and Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Indemnification of the Underwriters by the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors and officers and each person, if any, who controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out of, or are based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein, not misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any Written Testing-the-Waters Communication, any road show as defined in Rule 433(h) under the Securities Act (a &#8220;road show&#8221;) or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in paragraph (c) below. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Indemnification of the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication, any road show or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), it being understood and agreed upon that the only such information furnished by any Underwriter consists of the following information in the Prospectus furnished on behalf of each Underwriter&#58; the concession figures appearing in the fifth paragraph under the caption &#8220;Underwriting&#8221; and the information contained in the thirteenth paragraph relating to stabilizing transactions under the caption &#8220;Underwriting.&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Notice and Procedures.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this Section 7, such person (the &#8220;Indemnified Person&#8221;) shall promptly notify the person against whom such indemnification may be sought (the &#8220;Indemnifying Person&#8221;) in writing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under the preceding paragraphs of this Section 7 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided, further,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under the preceding paragraphs of this Section 7. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section that the Indemnifying Person may designate in such proceeding and shall pay the reasonably incurred and documented fees and expenses in such proceeding and shall pay the reasonably incurred and documented fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary&#59; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person&#59; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person&#59; or (iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the reasonably incurred fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such reasonably incurred and documented fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by the Representatives and any such separate firm for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for reasonably incurred and documented fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contribution.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> If the indemnification provided for in paragraphs (a) or (b) above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters on the other, from the offering of the Shares or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company, on the one hand, and the Underwriters on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriters on the other, shall be deemed to be in the same respective proportions as the net proceeds (after deducting underwriting discounts and commissions but before deducting expenses) received by the Company from the sale of the Shares and the total underwriting discounts and commissions received by the Underwriters in connection therewith, as set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of the Shares. The relative fault of the Company, on the one hand, and the Underwriters on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Limitation on Liability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to paragraph (d) above were determined by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (d) and (e), in no event shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Shares exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#8217; obligations to contribute pursuant to paragraphs (d) and (e) are several in proportion to their respective purchase obligations hereunder and not joint.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Non-Exclusive Remedies.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The remedies provided for in this Section 9 paragraphs (a) through (e) are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Effectiveness of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This Agreement shall become effective as of the date first written above. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This Agreement may be terminated in the absolute discretion of the Representatives, by notice to the Company, if after the execution and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date (i) trading generally shall have been suspended or materially limited on or by any of the New York Stock Exchange or The Nasdaq Stock Market&#59; (ii) trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any over-the-counter market&#59; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities&#59; or (iv) there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">              </font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Defaulting Underwriter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (a) If, on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the Shares that it has agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their discretion arrange for the purchase of such Shares by other persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters do not arrange for the purchase of such Shares, then the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the non-defaulting Underwriters to purchase such Shares on such terms. If other persons become obligated or agree to purchase the Shares of a defaulting Underwriter, either the non-defaulting Underwriters or the Company may postpone the Closing Date or the Additional Closing Date, as the case may be, for up to five full business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term &#8220;Underwriter&#8221; includes, for all purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section 10, purchases Shares that a defaulting Underwriter agreed but failed to purchase. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (b) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters, the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be, does not exceed one-eleventh of the aggregate number of Shares to be purchased on such date, then the Company shall have the right to require each non-defaulting Underwriter to purchase the number of Shares that such Underwriter agreed to purchase hereunder on such date plus such Underwriter&#8217;s pro rata share (based on the number of Shares that such Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (c) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the non-defaulting Underwriters, the Company as provided in paragraph (a) above, the aggregate number of Shares that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be, exceeds one-eleventh of the aggregate amount of Shares to be purchased on such date, or if the Company shall not exercise the right described in paragraph (b) above, then this Agreement or, with respect to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case may be, shall terminate without liability on the part of the non-defaulting Underwriters. Any termination of this Agreement pursuant to this Section 10 shall be without liability on the part of the Company, except that the Company will continue to be liable for the payment of expenses as set forth in Section 11 hereof and except that the provisions of Section 7 hereof shall not terminate and shall remain in effect. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter for damages caused by its default. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">           </font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Payment of Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (a) Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i) the preparation, printing and filing of the Registration Statement (including financial statements and exhibits) as originally filed and each amendment thereto, (ii) the preparation, printing and delivery to the Underwriters of copies of each preliminary prospectus, each Issuer Free Writing Prospectus, any Pricing Disclosure Package and the Prospectus and any amendments or supplements thereto and the reasonable costs associated with electronic delivery of any of the foregoing by the Underwriters to investors, (iii) the preparation, issuance and delivery of the certificates or security entitlements for the Shares to the Underwriters, including any stock or other transfer taxes and any stamp or other duties payable upon the sale, issuance or delivery of the Shares to the Underwriters, (iv) the fees and disbursements of the Company&#8217;s counsel, accountants and other advisors, (v) the qualification of the Shares under securities laws in accordance with the provisions of Section 5(h) hereof (including filing fees and the reasonable fees and disbursements of counsel for the Underwriters in connection therewith and in connection with the preparation of the Blue Sky Survey and any supplement thereto in an amount not to exceed $5,000), (vi) the fees and expenses of any transfer agent or registrar for the Shares, (vii) the costs and expenses of the Company relating to investor presentations on any &#8220;road show&#8221; undertaken in connection with the marketing of the Shares, including without limitation, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations, travel and lodging expenses of the representatives and officers of the Company and any such consultants (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> that the travel, lodging and any car travel expenses of the representatives of the Underwriters shall be paid by the Underwriters) and 50% of the cost of aircraft and other transportation chartered in connection with the road show, (viii) the filing fees incident to, and the reasonable fees and disbursements of counsel to the Underwriters in an amount not to exceed $30,000 in connection with, the review by FINRA of the terms of the sale of the Shares, (ix) the fees and expenses incurred in connection with the listing of the Shares on the Nasdaq Market and (x) the costs and expenses (including, without limitation, any damages or other amounts payable in connection with legal or contractual liability) associated with the reforming of any contracts for sale of the Shares made by the Underwriters caused by a breach of the representation contained in the second sentence of Section 3(e). </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (b) If (i) this Agreement is terminated pursuant to Section 11, (ii) the Company for any reason fails to tender the Shares for delivery to the Underwriters or (iii) the Underwriters decline to purchase the Shares for any reason permitted under this Agreement, the Company agrees to reimburse the Underwriters for all out-of-pocket costs and expenses (including the reasonable and documented fees and expenses of their counsel) reasonably incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Persons Entitled to Benefit of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein and the affiliates of each Underwriter referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from any Underwriter shall be deemed to be a successor merely by reason of such purchase. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriters contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters or the directors, officers, controlling persons or affiliates referred to in Section 7 hereof. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Certain Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. For purposes of this Agreement, (a) except where otherwise expressly provided, the term &#8220;affiliate&#8221; has the meaning set forth in Rule 405 under the Securities Act&#59; (b) the term &#8220;business day&#8221; means any day other than a day on which banks are permitted or required to be closed in New York City&#59; (c) the term &#8220;subsidiary&#8221; has the meaning set forth in Rule 405 under the Securities Act and (d) the term &#8220;significant subsidiary&#8221; has the meaning set forth in Rule 1-02 of Regulation S-X under the Exchange Act. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                15. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Compliance with USA Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                16. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">No Advisory or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company acknowledges and agrees that (a) the purchase and sale of the Shares pursuant to this Agreement, including the determination of the public offering price of the Shares and any related discounts and commissions, is an arm&#8217;s-length commercial transaction between the Company, on the one hand, and the Underwriters, on the other hand, (b) in connection with the offering of the Shares and the process leading thereto, the Underwriters are and have been acting solely as a principal and are not the agent or fiduciary of the Company, any of its subsidiaries, or its respective stockholders, creditors, employees or any other party, (c) the Underwriters have assumed and will assume no advisory or fiduciary responsibility in favor of the Company with respect to the offering of the Shares or the process leading thereto (irrespective of whether the Underwriters have advised or are currently advising the Company or any of its subsidiaries on other matters) and the Underwriters have no obligation to the Company with respect to the offering of the Shares except the obligations expressly set forth in this Agreement, (d) the Underwriters and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those of each of the Company, and (e) the Underwriters have not provided any legal, accounting, regulatory or tax advice with respect to the offering of the Shares and the Company has consulted their own respective legal, accounting, regulatory and tax advisors to the extent it deemed appropriate.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                17. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Notices.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives c&#47;o BofA Securities, Inc., One Bryant Park, New York, New York 10036, Attention&#58; Syndicate Department (fax&#58; (646) 855-3073), with a copy to ECM Legal (fax&#58; (212) 230-8730), and c&#47;o J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (fax&#58; (212) 622-8358)&#59; Attention&#58; Equity Syndicate Desk. Notices to the Company shall be given to it at Cardlytics, Inc., 675 Ponce de Leon Avenue NE, Suite 6000, Atlanta, Georgia 30308, Attention&#58; General Counsel.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Governing Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed in accordance with the laws of the State of New York. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Submission to Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Company and may be enforced in any court to the jurisdiction of which Company is subject by a suit upon such judgment. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Waiver of Jury Trial.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Recognition of the U.S. Special Resolution Regimes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                                (i) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                                (ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">              </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  As used in this Section 17(e)&#58; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                &#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                &#8220;Covered Entity&#8221; means any of the following&#58; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                                (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b)&#59; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                                (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b)&#59; or </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                                (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                &#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                &#8220;U.S. Special Resolution Regime&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Counterparts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same Agreement. Electronic signatures complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. &#167;&#167; 301-309), as amended from time to time, or other applicable law will be deemed original signatures for purposes of this Agreement. Transmission by telecopy, electronic mail or other transmission method of an executed counterpart of this Agreement will constitute due and sufficient delivery of such counterpart.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (g) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Amendments or Waivers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                (h) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Headings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. </font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                If the foregoing is in accordance with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below. </font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.625%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Very truly yours,</font></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CARDLYTICS, INC.</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Andy Christiansen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#58; Andy Christiansen</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Title&#58; Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accepted&#58; As of the date first written above </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BOFA SECURITIES, INC.  J.P. MORGAN SECURITIES LLC </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Acting severally on behalf of themselves </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and on behalf of the </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">several Underwriters listed </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in Schedule 1 hereto. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BOFA SECURITIES, INC. </font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.173%"><tr><td style="width:1.0%"></td><td style="width:12.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.442%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Magdalena Heinrich</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Authorized Signatory</font></td></tr></table></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> J.P. MORGAN SECURITIES LLC </font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:32.371%"><tr><td style="width:1.0%"></td><td style="width:11.276%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.544%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John Dunphy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Authorized Signatory</font></td></tr></table></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Schedule 1 </font></div><div style="margin-top:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.106%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwriter</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Number of Shares</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BofA Securities, Inc.</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,616,336</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">J.P. Morgan Securities LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,532,698</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Wells Fargo Securities, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">446,069</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Raymond James &#38; Associates, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">254,897</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:20pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,850,000</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Annex A </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">a. Pricing Disclosure Package </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                None. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">b. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Pricing Information Provided Orally by Underwriters</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                Public Offering Price&#58; $130.00 </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                Number of Underwritten Shares&#58; 3,850,000 </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                Number of Option Shares&#58; 577,500</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Annex B </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Written Testing-the-Waters Communications </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                None. </font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Annex C </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cardlytics, Inc. </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Pricing Term Sheet </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                None. </font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exhibit A </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">FORM OF LOCK-UP AGREEMENT</font></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">___________ ____, 2021 </font></div><div style="margin-top:6pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BofA SECURITIES, INC. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">J.P. MORGAN SECURITIES LLC</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As Representatives of </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the several Underwriters listed in </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Schedule 1 to the Underwriting </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Agreement referred to below </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">c&#47;o BofA Securities, Inc. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">One Bryant Park </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">New York, New York 10036</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">c&#47;o J.P. Morgan Securities LLC </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">383 Madison Avenue </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">New York, NY 10179 </font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:69.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Re&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cardlytics, Inc. &#8212; Public Offering</font></td></tr></table></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Ladies and Gentlemen&#58; </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                The undersigned understands that you, as Representatives of the several Underwriters, propose to enter into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Cardlytics, Inc., a Delaware corporation (the &#8220;Company&#8221;), providing for the public offering (the &#8220;Public Offering&#8221;) by the several Underwriters named in Schedule 1 to the Underwriting Agreement (the &#8220;Underwriters&#8221;) of common stock of the Company (the &#8220;Securities&#8221;). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                In consideration of the Underwriters&#8217; agreement to purchase and make the Public Offering of the Securities, and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of BofA Securities, Inc. and J.P. Morgan Securities LLC on behalf of the Underwriters, the undersigned will not, during the period beginning on the date of this letter agreement (this &#8220;Letter Agreement&#8221;) and ending 60 days after the date of the prospectus relating to the Public Offering (the &#8220;Prospectus&#8221;) (such period, the &#8220;Restricted Period&#8221;), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock, $0.0001 per share par value, of the Company (the &#8220;Common Stock&#8221;) or any securities convertible into or exercisable or exchangeable for Common Stock (including without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant), or publicly disclose the intention to undertake any of the foregoing, (2) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Common Stock or such other securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise, or (3) make any demand for or exercise any right with respect to the registration of any shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock. The undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition of any shares of Common Stock, or securities convertible into or exercisable or exchangeable for Common Stock, even if any such sale or disposition transaction or transactions would be made or executed by or on behalf of someone other than the undersigned. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                Notwithstanding the foregoing, and subject to the applicable conditions below, the undersigned may transfer Common Stock without the prior written consent of BofA Securities, Inc. and J.P. Morgan Securities LLC&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">provided that (i) BofA Securities, Inc. and J.P. Morgan Securities LLC receive a signed lock-up agreement for the balance of the Restricted Period from each donee, trustee, distributee, or transferee, as the case may be, (ii) any such transfer shall not involve a disposition for value, (iii) any such transfer is not required to be reported with the Securities and Exchange Commission on Form 4 in accordance with Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and (iv) the undersigned does not otherwise voluntarily effect any public filing or report regarding such transfers during the Restricted Period&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:18pt">as a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> gift or gifts or for </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> estate planning purposes&#59; or</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:18pt">by will or intestate succession upon the death of the undersigned, including to the transferee&#8217;s nominee or custodian&#59; or</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:18pt">to any trust or other entity for the direct or indirect benefit of the undersigned or the immediate family of the undersigned (for purposes of this Letter Agreement, &#8220;immediate family&#8221; shall mean any relationship by blood, marriage or adoption, not more remote than first cousin) or if the undersigned is a trust, to any beneficiary of the undersigned (including such beneficiary&#8217;s estate)&#59; or</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-28.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:18pt">as a distribution to limited partners, general partners, limited liability company members, stockholders or other equity holders of the undersigned&#59; or</font></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-25.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:18pt">to the undersigned&#8217;s affiliates or to any investment fund or other entity controlled or managed by the undersigned&#59; or</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">to the Company upon exercise of any right in respect of any option granted under any incentive plan of the Company described in the Prospectus or any warrant to purchase securities of the Company described in the Prospectus including the surrender of shares of Common Stock to the Company in &#8220;net&#8221; or &#8220;cashless&#8221; exercise of any option or warrant&#59; provided that (i) the shares of Common Stock received by the undersigned upon exercise continue to be subject to the restrictions on transfer set forth in this Letter Agreement, (ii) no filings are required or made pursuant to Section 16 of the Exchange Act during the Restricted Period&#59; or</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction made to all holders of Common Stock involving a Change of Control (as defined below) of the Company, provided that in the event that such tender offer, merger, consolidation or other such transaction is not completed, the Common Stock owned by the undersigned shall remain subject to the provisions of this Letter Agreement&#59; or </font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:10.5pt">&#91;pursuant to the terms a 10b5-1 trading plan in existence on the date hereof, provided that to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the undersigned regarding such sale, such announcement or filing shall include a statement to the effect that such sale was made pursuant to a 10b5-1 trading plan&#59; or&#93;&#91;1&#93;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:11.07pt">pursuant to an order of a court of competent jurisdiction or in connection with a divorce settlement, provided that the undersigned shall use its reasonable best efforts to cause the transferee to agree in writing to be bound by the terms of this Letter Agreement prior to such transfer. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                For purposes of clause (c) above, &#8220;Change of Control&#8221; shall mean the consummation of any bona fide third party tender offer, merger, consolidation or other similar transaction the result of which is that any &#8220;person&#8221; (as defined in Section 13(d)(3) of the Exchange Act), or group of persons, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of more than 50% of total voting power of the voting stock of the Company.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                Furthermore, during the Restricted Period, the undersigned may sell shares of Common Stock of the Company purchased by the undersigned in the Public Offering or in open market transactions following the Public Offering if and only if (i) such sales are not required to be reported with the Securities and Exchange Commission on Form 4 in accordance with Section 16 of the Exchange Act and (ii) the undersigned does not otherwise voluntarily effect any public filing or report regarding such sales during the Restricted Period.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                Nothing herein shall prevent the undersigned from establishing a 10b5-1 trading plan that complies with Rule 10b5-1 under the Exchange Act (&#8220;10b5-1 trading plan&#8221;) so long as there are no sales of Common Stock under such plans during the Restricted Period&#59; and provided that the establishment of a 10b5-1 trading plan or the amendment of a 10b5-1 trading plan shall only be permitted if (i) the establishment of such plan is not required to be reported in any public report or filing with the Securities and Exchange Commission, or otherwise and (ii) the undersigned does not otherwise voluntarily effect any public filing or report regarding the establishment of such plan during the Restricted Period.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Letter Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                The undersigned acknowledges and agrees that the Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any action from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although the Representatives may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection with the Public Offering, the Representatives and the other Underwriters are not making a recommendation to you to enter into this Letter Agreement, and nothing set forth in such disclosures is intended to suggest that the Representatives or any Underwriter is making such a recommendation.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                This Letter Agreement may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                The undersigned understands that, if the Underwriting Agreement does not become effective by March 31, 2021, if the Company advises BofA Securities, Inc. and J.P. Morgan Securities LLC in writing that it has determined not to proceed with the Public Offering, or if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be sold thereunder, the undersigned shall be released from all obligations under this Letter Agreement. The undersigned understands that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Letter Agreement.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">                This Letter Agreement and any claim, controversy or dispute arising under or related to this Letter Agreement shall be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Very truly yours, </font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.993%"><tr><td style="width:1.0%"></td><td style="width:42.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.480%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">IF AN INDIVIDUAL&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">IF AN ENTITY&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(duly authorized signature)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(please print complete name of entity)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(please print full name)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(duly authorized signature)</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(please print full name)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;1&#93; To be included in lockup agreements for executive officers.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>a51cooleyllpopinion_2021x8k.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="icfa9b55d3ec64854b0a81e4e05298822_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 5.1</font></div><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><img alt="image1a.jpg" src="image1a.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:136px"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 5, 2021</font></div><div style="margin-top:6pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cardlytics, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">675 Ponce de Leon Avenue NE, Suite 6000</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Atlanta, Georgia 30308</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Ladies and Gentlemen&#58;</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have acted as counsel to Cardlytics, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), in connection with the sale of up to 4,427,500 shares of its common stock, par value $0.0001 per share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), which includes 577,500 Shares that may be sold upon exercise of an over-allotment option to be granted to the underwriters, pursuant to the Registration Statement on Form S-3 (File No. 333-253697) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) filed with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), the prospectus included in the Registration Statement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Base Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) and the prospectus supplement dated March 1, 2020, and filed with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;). </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with this opinion, we have examined and relied upon the Registration Statement and the Prospectus, the Company&#8217;s certificate of incorporation and bylaws, each as currently in effect, and such other documents, records, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies, the accuracy, completeness and authenticity of certificates of public officials, and the due authorization, execution and delivery of all documents by all persons other than the Company where authorization, execution and delivery are prerequisites to the effectiveness thereof. As to certain factual matters, we have relied upon a certificate of an officer of the Company and have not independently verified such matters. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our opinion is expressed only with respect to the General Corporation Law of the State of Delaware. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued in accordance with the Registration Statement and the Prospectus, will be validly issued, fully paid, and nonassessable.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated. Our opinion is based on these laws as in effect on the date hereof, and we disclaim any obligation to advise you of facts, circumstances, events or developments which hereafter may be brought to our attention and which may alter, affect or modify the opinion expressed herein. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We consent to the reference to our firm under the caption &#8220;Legal Matters&#8221; in the Prospectus and to the filing of this opinion as an exhibit to the Company&#8217;s Current Report on Form 8-K filed with the Commission for incorporation by reference in the Registration Statement.</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Very truly yours,</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cooley LLP</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47;  Nicole C. Brookshire      </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">        Nicole C. Brookshire </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Cooley LLP   500 Boylston Street   Boston, MA   02116-3736 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">t&#58; (617) 937-2300  f&#58; (617) 937-2400  cooley.com</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>a231cooleyllpconsent_2021x.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i10a219be37494da4a1b901a5c7b55a92_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><img alt="image1a.jpg" src="image1a.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:136px"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 5, 2021</font></div><div style="margin-top:6pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cardlytics, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">675 Ponce de Leon Avenue NE, Suite 6000</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Atlanta, Georgia 30308</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Ladies and Gentlemen&#58;</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have acted as counsel to Cardlytics, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), in connection with the sale of up to 4,427,500 shares of its common stock, par value $0.0001 per share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), which includes 577,500 Shares that may be sold upon exercise of an over-allotment option to be granted to the underwriters, pursuant to the Registration Statement on Form S-3 (File No. 333-253697) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) filed with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;), the prospectus included in the Registration Statement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Base Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) and the prospectus supplement dated March 1, 2020, and filed with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;) pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;). </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with this opinion, we have examined and relied upon the Registration Statement and the Prospectus, the Company&#8217;s certificate of incorporation and bylaws, each as currently in effect, and such other documents, records, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies, the accuracy, completeness and authenticity of certificates of public officials, and the due authorization, execution and delivery of all documents by all persons other than the Company where authorization, execution and delivery are prerequisites to the effectiveness thereof. As to certain factual matters, we have relied upon a certificate of an officer of the Company and have not independently verified such matters. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our opinion is expressed only with respect to the General Corporation Law of the State of Delaware. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued in accordance with the Registration Statement and the Prospectus, will be validly issued, fully paid, and nonassessable.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated. Our opinion is based on these laws as in effect on the date hereof, and we disclaim any obligation to advise you of facts, circumstances, events or developments which hereafter may be brought to our attention and which may alter, affect or modify the opinion expressed herein. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We consent to the reference to our firm under the caption &#8220;Legal Matters&#8221; in the Prospectus and to the filing of this opinion as an exhibit to the Company&#8217;s Current Report on Form 8-K filed with the Commission for incorporation by reference in the Registration Statement.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Very truly yours,</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cooley LLP</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47;  Nicole C. Brookshire      </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">        Nicole C. Brookshire </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Cooley LLP   500 Boylston Street   Boston, MA   02116-3736 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">t&#58; (617) 937-2300  f&#58; (617) 937-2400  cooley.com</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>cdlx_exx991x0301pressrelea.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia3fad231919249fe815986858c706393_32"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cardlytics Announces Launch of Offering of $500 million of Shares of Common Stock</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ATLANTA, March 01, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Cardlytics, Inc. (NASDAQ&#58; CDLX), an advertising platform in banks&#8217; digital channels, today announced that it has commenced an underwritten public offering of $500 million of shares of common stock. All of the shares of common stock to be sold in the offering will be offered by Cardlytics. In addition, Cardlytics expects to grant the underwriters a 30-day option to purchase up to an additional $75 million of shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BofA Securities and J.P. Morgan are acting as joint book-running managers and representatives of the underwriters for the offering. Wells Fargo Securities is also acting as a book-running manager for this offering. Raymond James is acting as a manager for the offering.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A registration statement (including a base prospectus) and a preliminary prospectus supplement relating to these securities have been filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;). The registration statement became effective on March 1, 2021. The offering is being made only by means of a prospectus supplement (including the accompanying base prospectus), copies of which may be obtained from BofA Securities, Inc., 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attention&#58; Prospectus Department, or by email at dg.prospectus_requests&#64;bofa.com&#59; or J.P. Morgan Securities LLC, c&#47;o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or telephone at 866-803-9204 or email at prospectus-eq_fi&#64;jpmchase.com.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About Cardlytics</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardlytics (NASDAQ&#58; CDLX) is an advertising platform in banks&#8217; digital channels. We partner with financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. In turn, we have a secure view into where and when consumers are spending their money. We use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in London, New York, San Francisco, and Visakhapatnam.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward Looking Statements</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release includes certain disclosures which contain &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding Cardlytics&#8217; expectations regarding the proposed public offering. The words &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will&#8221; and similar expressions are intended to identify forward-looking statements. Forward-looking statements are based on Cardlytics&#8217; current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include risks related to market conditions and other factors that are set forth in Cardlytics&#8217; filings with the SEC, including Cardlytics&#8217; Annual Report on Form 10-K for the year ended December 31, 2020 and other filings Cardlytics makes with the SEC from time to time, under the caption &#8220;Risk Factors.&#8221; The forward-looking statements speak only as of the date made and, other than as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contacts&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public Relations&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Angie Amberg</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardlytics, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aamberg&#64;cardlytics.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investor Relations&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">William Maina</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICR, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(646) 277-1236</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ir&#64;cardlytics.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>cdlx_exx992x0302pressrelea.htm
<DESCRIPTION>EX-99.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6314cb5e6d2245be9812cbb2cd06756b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.2</font></div></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:107%">Cardlytics Announces Pricing of Public Offering of Common Stock</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ATLANTA, March 02, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> - Cardlytics, Inc. (NASDAQ&#58; CDLX), a digital advertising platform, today announced the pricing of an underwritten public offering of 3,850,000 shares of its common stock, at a price to the public of $130.00 per share. The gross proceeds to Cardlytics from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $500.5 million. The offering is expected to close on or about March 5, 2021, subject to customary closing conditions. In addition, Cardlytics has granted the underwriters a 30-day option to purchase up to an additional 577,500 shares of common stock at the public offering price, less underwriting discounts and commissions.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BofA Securities and J.P. Morgan are acting as joint book-running managers and representatives of the underwriters for the offering. Wells Fargo Securities is also acting as a book-running manager for the offering. Raymond James is acting as a manager for the offering.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The offering is being made pursuant to a shelf registration statement, including a base prospectus, filed by Cardlytics with the Securities and Exchange Commission (SEC), which was effective on March 1, 2021. The offering may be made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC&#8217;s website at www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus may also be obtained, when available, from BofA Securities, Inc., 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attention&#58; Prospectus Department, or by email at dg.prospectus_requests&#64;bofa.com&#59; or J.P. Morgan Securities LLC, c&#47;o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or telephone at 866-803-9204 or email at prospectus-eq_fi&#64;jpmchase.com.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About Cardlytics</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardlytics (NASDAQ&#58; CDLX) is an advertising platform in banks&#8217; digital channels. We partner with financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. In turn, we have a secure view into where and when consumers are spending their money. We use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in London, New York, San Francisco, and Visakhapatnam.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward Looking Statements</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release includes certain disclosures which contain &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding Cardlytics&#8217; expectations regarding the closing of the public offering. The words &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will&#8221; and similar expressions are intended to identify forward-looking statements. Forward-looking statements are based on Cardlytics&#8217; current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include risks related to the satisfaction of closing conditions and other factors that are set forth in Cardlytics&#8217; filings with the SEC, including Cardlytics&#8217; Annual Report on Form 10-K for the year ended December 31, 2020 and other filings Cardlytics makes with the SEC from time to time, under the caption &#8220;Risk Factors.&#8221; The forward-looking statements speak only as of the date made and, other than as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.2</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contacts&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public Relations&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Angie Amberg</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardlytics, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">aamberg&#64;cardlytics.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investor Relations&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">William Maina</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICR, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(646) 277-1236</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ir&#64;cardlytics.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>cdlx-20210302.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7576783-1552-4e70-af69-63513d6bcbf1,g:4bbd941e-7b64-4c72-8c4c-f13d72de5131-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cdlx="http://www.cardlytics.com/20210302" xmlns:xbrli="http://www.xbrl.org/2003/instance" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cardlytics.com/20210302">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdlx-20210302_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdlx-20210302_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdlx-20210302_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cdlx-20210302_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.cardlytics.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cdlx_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cdlx_Titleof12bSecurity" abstract="false" name="Titleof12bSecurity" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:normalizedStringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>cdlx-20210302_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7576783-1552-4e70-af69-63513d6bcbf1,g:4bbd941e-7b64-4c72-8c4c-f13d72de5131-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cardlytics.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="cdlx-20210302.xsd#DocumentandEntityInformation"/>
  <link:calculationLink xlink:role="http://www.cardlytics.com/role/DocumentandEntityInformation" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>cdlx-20210302_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7576783-1552-4e70-af69-63513d6bcbf1,g:4bbd941e-7b64-4c72-8c4c-f13d72de5131-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cardlytics.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="cdlx-20210302.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.cardlytics.com/role/DocumentandEntityInformation" xlink:type="extended" id="i6f6952056f354fa29c8b74b7f2636be8_DocumentandEntityInformation">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5865d85e-6f76-4995-a01d-0d5e31143a8d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_DocumentType_5865d85e-6f76-4995-a01d-0d5e31143a8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ec5295a5-dd33-4407-a3ba-41ce5ceced49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_AmendmentFlag_ec5295a5-dd33-4407-a3ba-41ce5ceced49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9be57cd4-efeb-4f08-bfd1-abf7be4ed1e3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_DocumentPeriodEndDate_9be57cd4-efeb-4f08-bfd1-abf7be4ed1e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3a4b1351-19ae-41d2-a54c-326787da6b6e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityRegistrantName_3a4b1351-19ae-41d2-a54c-326787da6b6e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fa1ba26a-1623-4346-82a3-836d9727db87" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityCentralIndexKey_fa1ba26a-1623-4346-82a3-836d9727db87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_008fdff2-06c5-45a0-a53d-98a4dabdd6b2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityEmergingGrowthCompany_008fdff2-06c5-45a0-a53d-98a4dabdd6b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7556652a-3ccc-4cb4-aa07-95bef3983c67" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7556652a-3ccc-4cb4-aa07-95bef3983c67" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ff99b0b4-0dd6-4e7d-a674-12bdfce0aa6b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityFileNumber_ff99b0b4-0dd6-4e7d-a674-12bdfce0aa6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cd820fe2-948e-4406-9931-4e548ed7ccc9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityTaxIdentificationNumber_cd820fe2-948e-4406-9931-4e548ed7ccc9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_663b20e9-22ac-4eb8-a881-9d6454f7c766" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityAddressAddressLine1_663b20e9-22ac-4eb8-a881-9d6454f7c766" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_762cc659-e987-4791-aec1-e31dd1b32410" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityAddressCityOrTown_762cc659-e987-4791-aec1-e31dd1b32410" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_46cb91a0-0f6e-46da-8ca9-e3875b093713" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityAddressStateOrProvince_46cb91a0-0f6e-46da-8ca9-e3875b093713" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ccc8e178-ac8c-45ee-97e2-eddfb1b7958f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityAddressPostalZipCode_ccc8e178-ac8c-45ee-97e2-eddfb1b7958f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ddf586c9-0ce3-4172-87ed-0ca52d60f68e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_CityAreaCode_ddf586c9-0ce3-4172-87ed-0ca52d60f68e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_08b538e2-2592-4efc-8b70-009da642a9ab" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_LocalPhoneNumber_08b538e2-2592-4efc-8b70-009da642a9ab" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d670a7b5-0667-4732-a07e-0c3336dede6d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_WrittenCommunications_d670a7b5-0667-4732-a07e-0c3336dede6d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_1870b4f9-002c-4226-ad76-f5fe51d428cc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_SolicitingMaterial_1870b4f9-002c-4226-ad76-f5fe51d428cc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_a7552c69-e5ac-4e1b-b7b6-bf6c2bf91001" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_PreCommencementTenderOffer_a7552c69-e5ac-4e1b-b7b6-bf6c2bf91001" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdlx_Titleof12bSecurity_fd13bd97-8f22-41a2-b2e4-b1492f971df5" xlink:href="cdlx-20210302.xsd#cdlx_Titleof12bSecurity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_cdlx_Titleof12bSecurity_fd13bd97-8f22-41a2-b2e4-b1492f971df5" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3078cf9e-3eba-4655-ac1e-b46070cb1c21" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_SecurityExchangeName_3078cf9e-3eba-4655-ac1e-b46070cb1c21" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_00dfd9e7-ff09-4f84-a488-a11d7802d266" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_00dfd9e7-ff09-4f84-a488-a11d7802d266" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5ecece91-4213-4d5e-98d6-e8af48b7578c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_TradingSymbol_5ecece91-4213-4d5e-98d6-e8af48b7578c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5e0ae62e-bf25-464a-8273-39f7ace6206b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntitiesTable_5e0ae62e-bf25-464a-8273-39f7ace6206b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_875faffa-73e5-40f6-92cd-a162111ea39b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_5e0ae62e-bf25-464a-8273-39f7ace6206b" xlink:to="loc_dei_LegalEntityAxis_875faffa-73e5-40f6-92cd-a162111ea39b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_875faffa-73e5-40f6-92cd-a162111ea39b_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_875faffa-73e5-40f6-92cd-a162111ea39b" xlink:to="loc_dei_EntityDomain_875faffa-73e5-40f6-92cd-a162111ea39b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_44afafa8-754e-4a4f-ae4f-af0b5fe874bd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_875faffa-73e5-40f6-92cd-a162111ea39b" xlink:to="loc_dei_EntityDomain_44afafa8-754e-4a4f-ae4f-af0b5fe874bd" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>cdlx-20210302_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7576783-1552-4e70-af69-63513d6bcbf1,g:4bbd941e-7b64-4c72-8c4c-f13d72de5131-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9010738f-ad53-47e6-9e5b-418b6d40aa5c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cdlx_DocumentAndEntityInformationAbstract_70bb13bb-3070-478a-a006-6e8db735110c_terseLabel_en-US" xlink:label="lab_cdlx_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_cdlx_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_cdlx_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_cdlx_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_cdlx_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cdlx_DocumentAndEntityInformationAbstract" xlink:href="cdlx-20210302.xsd#cdlx_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cdlx_DocumentAndEntityInformationAbstract" xlink:to="lab_cdlx_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_58aca790-c485-4bcd-b435-614b1f5c43aa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_b67b4691-b6d1-40a4-a23a-4468e9c7f1d0_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_747d9052-0848-4aec-b805-382f6e09a58a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_20d4a25b-1288-4fdc-ba9b-f80a9de16357_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_0283cbf8-3a7b-40d1-9e60-6ff708fed2ab_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_38f65594-8827-455b-8a25-b1718b462253_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_cda4ab84-7a70-4b4b-b780-3bb3c6ff19dd_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9602cca9-475e-467c-be3d-c888693463ad_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9f29d4f1-8116-4aab-9c6a-064df6638790_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a129eb79-f53d-490a-a089-520bcad2bd45_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a2730b5b-d65e-4e22-b7e7-1c3fea5999de_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ccb18b32-6a48-4390-bf12-67f6a7805508_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8dd66bc9-4501-4762-9b3b-3ab0cda383f1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_54f0f0f9-e638-48d6-a385-ddd828decf25_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5d5e3ba6-c23e-45e8-82da-7ffdb918d264_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_3e2b4cf0-4fe7-45b2-8319-904b65591627_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cbb140c6-91e9-422f-986b-ffda7e825eac_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c41865ee-4055-4b59-a4f4-b0b35cb5dc63_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_46a0322e-d6ae-475c-8e59-8b5421951bec_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_cdlx_Titleof12bSecurity_a6afbff4-3d1b-443e-99b3-024025912db1_terseLabel_en-US" xlink:label="lab_cdlx_Titleof12bSecurity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_cdlx_Titleof12bSecurity_label_en-US" xlink:label="lab_cdlx_Titleof12bSecurity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_cdlx_Titleof12bSecurity_documentation_en-US" xlink:label="lab_cdlx_Titleof12bSecurity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cdlx_Titleof12bSecurity" xlink:href="cdlx-20210302.xsd#cdlx_Titleof12bSecurity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cdlx_Titleof12bSecurity" xlink:to="lab_cdlx_Titleof12bSecurity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_6865f7d9-723e-401f-94d8-7f384bd240ae_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d00da00e-d7e4-423c-9b9e-ba2228111571_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_85d6e25b-e6f6-4898-8635-6f33486c9be6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_5fd6f835-3952-4aac-8ef7-b6dbeb925926_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_570bef3f-e9ac-4407-acf0-ee69a271094b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>cdlx-20210302_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7576783-1552-4e70-af69-63513d6bcbf1,g:4bbd941e-7b64-4c72-8c4c-f13d72de5131-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cardlytics.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="cdlx-20210302.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.cardlytics.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cdlx_DocumentAndEntityInformationAbstract_58935fdb-5d27-43b7-bb6a-954353df7d9b" xlink:href="cdlx-20210302.xsd#cdlx_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5e0ae62e-bf25-464a-8273-39f7ace6206b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cdlx_DocumentAndEntityInformationAbstract_58935fdb-5d27-43b7-bb6a-954353df7d9b" xlink:to="loc_dei_EntitiesTable_5e0ae62e-bf25-464a-8273-39f7ace6206b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_875faffa-73e5-40f6-92cd-a162111ea39b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5e0ae62e-bf25-464a-8273-39f7ace6206b" xlink:to="loc_dei_LegalEntityAxis_875faffa-73e5-40f6-92cd-a162111ea39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_44afafa8-754e-4a4f-ae4f-af0b5fe874bd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_875faffa-73e5-40f6-92cd-a162111ea39b" xlink:to="loc_dei_EntityDomain_44afafa8-754e-4a4f-ae4f-af0b5fe874bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5e0ae62e-bf25-464a-8273-39f7ace6206b" xlink:to="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5865d85e-6f76-4995-a01d-0d5e31143a8d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_DocumentType_5865d85e-6f76-4995-a01d-0d5e31143a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ec5295a5-dd33-4407-a3ba-41ce5ceced49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_AmendmentFlag_ec5295a5-dd33-4407-a3ba-41ce5ceced49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9be57cd4-efeb-4f08-bfd1-abf7be4ed1e3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_DocumentPeriodEndDate_9be57cd4-efeb-4f08-bfd1-abf7be4ed1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3a4b1351-19ae-41d2-a54c-326787da6b6e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityRegistrantName_3a4b1351-19ae-41d2-a54c-326787da6b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fa1ba26a-1623-4346-82a3-836d9727db87" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityCentralIndexKey_fa1ba26a-1623-4346-82a3-836d9727db87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_008fdff2-06c5-45a0-a53d-98a4dabdd6b2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityEmergingGrowthCompany_008fdff2-06c5-45a0-a53d-98a4dabdd6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7556652a-3ccc-4cb4-aa07-95bef3983c67" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7556652a-3ccc-4cb4-aa07-95bef3983c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ff99b0b4-0dd6-4e7d-a674-12bdfce0aa6b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityFileNumber_ff99b0b4-0dd6-4e7d-a674-12bdfce0aa6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_cd820fe2-948e-4406-9931-4e548ed7ccc9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityTaxIdentificationNumber_cd820fe2-948e-4406-9931-4e548ed7ccc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_663b20e9-22ac-4eb8-a881-9d6454f7c766" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityAddressAddressLine1_663b20e9-22ac-4eb8-a881-9d6454f7c766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_762cc659-e987-4791-aec1-e31dd1b32410" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityAddressCityOrTown_762cc659-e987-4791-aec1-e31dd1b32410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_46cb91a0-0f6e-46da-8ca9-e3875b093713" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityAddressStateOrProvince_46cb91a0-0f6e-46da-8ca9-e3875b093713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ccc8e178-ac8c-45ee-97e2-eddfb1b7958f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_EntityAddressPostalZipCode_ccc8e178-ac8c-45ee-97e2-eddfb1b7958f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ddf586c9-0ce3-4172-87ed-0ca52d60f68e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_CityAreaCode_ddf586c9-0ce3-4172-87ed-0ca52d60f68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_08b538e2-2592-4efc-8b70-009da642a9ab" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_LocalPhoneNumber_08b538e2-2592-4efc-8b70-009da642a9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d670a7b5-0667-4732-a07e-0c3336dede6d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_WrittenCommunications_d670a7b5-0667-4732-a07e-0c3336dede6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_1870b4f9-002c-4226-ad76-f5fe51d428cc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_SolicitingMaterial_1870b4f9-002c-4226-ad76-f5fe51d428cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_a7552c69-e5ac-4e1b-b7b6-bf6c2bf91001" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_PreCommencementTenderOffer_a7552c69-e5ac-4e1b-b7b6-bf6c2bf91001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cdlx_Titleof12bSecurity_fd13bd97-8f22-41a2-b2e4-b1492f971df5" xlink:href="cdlx-20210302.xsd#cdlx_Titleof12bSecurity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_cdlx_Titleof12bSecurity_fd13bd97-8f22-41a2-b2e4-b1492f971df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3078cf9e-3eba-4655-ac1e-b46070cb1c21" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_SecurityExchangeName_3078cf9e-3eba-4655-ac1e-b46070cb1c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_00dfd9e7-ff09-4f84-a488-a11d7802d266" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_00dfd9e7-ff09-4f84-a488-a11d7802d266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5ecece91-4213-4d5e-98d6-e8af48b7578c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5f62132a-c3d2-4102-8463-2def8c035c5e" xlink:to="loc_dei_TradingSymbol_5ecece91-4213-4d5e-98d6-e8af48b7578c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>cdlx-20210302_g1.jpg
<TEXT>
begin 644 cdlx-20210302_g1.jpg
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M 0$! 0$! 0$! 0'_P  1"  X /D# 1$  A$! Q$!_\0 '@   @(" P$!
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MGV.IS[\)SGU3ZIS.TVU2]O8+61F5)68,R8W#$;N,;@PZJ,Y'3/MIFXD,,+R
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M!!^J6O\ @?\ )JGB)QZ)QC_-C&/^6.?'QY)/KKIF. !ZJ^\2EJ-KAIG3^PI
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944<**.%%'"BCA11PHHX44<**.%%'"BO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image1a.jpg
<TEXT>
begin 644 image1a.jpg
MB5!.1PT*&@H    -24A$4@   (@    L" 8   "^-_"J   '+TE$051X >V;
MOXLD113'^T\Q,S,1 \% $ P$ S'12*/++M)$3,1 ,) +#H0+Q$0CC2Z[2!,Q
M$0/!0! ,Q,#USO/6];SU]%H^ V^H_>ZW?G7/[.[L=,'0/=-5]7[4]WW?J^K=
M85S:1CQP^YD7QU\?>W+]N?O*E8W,>]Z3#.>MP&61OP!$5O*?;[\;C[_^9OUY
M^.-/TF._ONXU0!X].!X?W/IB/'S[O5$=D=+JP>-/CU#KT8<?C_\=W-XKA*A?
M]B;%W/_LYOC;4\^O<VL*B-H]@-H7H.P=0!Y^_\-XY[F7)P$C!<[!$\^.QU]^
M=>G99*\ \O?-6R/I(EWH.?='UVXL -E1#YS:Q5 _E,  JQR]?WTD]:1%ZE\?
M?3K>N_J6K5$6@.PH.L9Q/ $0"M$<.  &.Y>61C_ $G,M &GQVL7LLP8(-4<N
MK< 8[&1Z&T"AP%T TNNYB]-_#1"V91'QZ94T,J>QBX&9+GN[U$5J+K7 '&?=
M8#+J( ";?DA9U#V;VC9O6LX<@*QTN7;CA+W8_L>5-U8V/[IWF%T&_)'6@MQ/
M.;1$!YV'K+%BD-]?>OT4>]QYX=5):25K2>4!1CD]4C:+^ZDI#Q6V)6<*0$C!
M^#GL*EU7-AN@ ! M#4CK/26!FP.]:,._/_]B%9R"P@H&LH]A##6RY"R>]13-
M(7B;<GH!0EU6LU&?(X/UTO;GNQ^<FHM=96MSXZ,L&-RV%GH[BP9UMK*&.BN^
MHW^M$4W;EM,#$.?SL(=KB54<2!P#M+*(&QOL@5^'PS??F86^VN+DGK-H=U^[
M>DHV#L()Y%^BC$,[Z!70YECF_B>?Y\2L?F>N= 'B/B<GGNNU)*<5(#"SVL%W
M;%5VH"; ;M4#>[0Y%FAA$0?6U,[!*1#THDIL\CO*J^%\+]47N?H!!Q,)KIV5
MG%: *%@9I\!0.UPZHJA,FV."&HL0I/1)UT''#.Y]"\C=9G/&H&3K.YOT$"Z,
M(X*TD<+4 7/EN.A%;@M =+<(L%MK/65ZIT<OB[C@4=897+[;-D"<8KSY;6T
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M0<*_(3^]TA\[4Z:&-0"#[M88Y^J@5)^XQ_[<NM2 R1RG ,*/(%8-3HWIO7<
M"3G.^)[YW98SG!-7'#U7#BFL%+7JKQQ T,FQ9X_-C.]ICD4(MI9F <) Z)"<
MUZ.XZ\L<:52H4CQSE;6;*_V-J !XI45+91%)4^0@LX72>P!22I6IC>X>%FNU
M.>QW.[Y6!LH")":'38@&IVSI-PPI 2/FCRM;OM8HGU(T3Y8CK]5C'KWV "3&
MKO[DL/&_%ZE!6E)"S)U>=<?'7*T@JP(D!$'3;$5A!'4&0"&BB5"BFKY3&E$.
MLEVD8Q2@V\2+Q&W(06]LCT_K&0<+15_\JK4" </O<VP&5!K(K>S!&C8#9,J"
M+V/.WP/*_H"0\J&U+0!I]=0.]J,\4/:@8.UI"T!ZO+5C?4E/*4!@#])K3UL
MTN.M'>J["?; W 4@.[3H/:JZLQ9 T]L6@/1Z; ?ZDT9T1T2ZF=(6@$SQV@4?
MXTY.I[ '9BX N>"+W:N>8X_2L7]M_@4@-0_MV'/''E-/8#%] <B. :"D+J>R
MZ9\%L,5M>:5?FG,!2,D[._:,$U+^1"+]3'WM$:;_#\7T@C(%KZD,     $E%
&3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>cdlx-20210302_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cdlx="http://www.cardlytics.com/20210302"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cdlx-20210302.xsd" xlink:type="simple"/>
    <context id="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001666071</identifier>
        </entity>
        <period>
            <startDate>2021-03-02</startDate>
            <endDate>2021-03-02</endDate>
        </period>
    </context>
    <context id="i630c736911e24f078cbdfd685d0b516c_D20200930-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001666071</identifier>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i630c736911e24f078cbdfd685d0b516c_D20200930-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF80L2ZyYWc6NWEzMDU5N2U4YTgxNGQ0MDlhN2FkNzFiNDVkOWYyNDUvdGFibGU6OGY4NTU5NTUzNjY1NGU0NGJmMTI2MjU1N2E3NjgxY2MvdGFibGVyYW5nZTo4Zjg1NTk1NTM2NjU0ZTQ0YmYxMjYyNTU3YTc2ODFjY18yLTEtMS0xLTA_234192d7-8855-41dc-b741-c3e63bf2ef23">0001666071</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i630c736911e24f078cbdfd685d0b516c_D20200930-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF80L2ZyYWc6NWEzMDU5N2U4YTgxNGQ0MDlhN2FkNzFiNDVkOWYyNDUvdGFibGU6OGY4NTU5NTUzNjY1NGU0NGJmMTI2MjU1N2E3NjgxY2MvdGFibGVyYW5nZTo4Zjg1NTk1NTM2NjU0ZTQ0YmYxMjYyNTU3YTc2ODFjY181LTEtMS0xLTA_974c8b9a-5c5f-4252-89e6-ae10519c4ce8">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGV4dHJlZ2lvbjo3NDM5ZGRlZjdlODM0NGRkYTcwZjQzZTcxNGI5YzllYl8xMDg5_3adfd1b1-cd04-419f-a665-0585ec65015e">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGV4dHJlZ2lvbjo3NDM5ZGRlZjdlODM0NGRkYTcwZjQzZTcxNGI5YzllYl8yMjk_e06ad081-3fa3-42b1-af5a-7996cd47ce5d">2021-03-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGV4dHJlZ2lvbjo3NDM5ZGRlZjdlODM0NGRkYTcwZjQzZTcxNGI5YzllYl8xMDg3_cf73f3f6-b822-4194-8325-67ce6b4ab41c">CARDLYTICS,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18wLTAtMS0xLTA_10af08e1-0a93-4eb0-862d-e3ce7c617ef3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18wLTEtMS0xLTA_5626b514-0809-482a-8e39-d4b2f590d37e">001-38386</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18wLTMtMS0xLTA_3c0a6f23-ed7f-463b-b2b1-65907552b9c0">26-3039436</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18yLTAtMS0xLTA_2e5bac9d-25a1-418b-9b7c-eaba1c876f83">675 Ponce de Leon Avenue NE, Suite 6000</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18yLTEtMS0xLTA_3ea23e9a-bc09-41a2-a731-b69c5209f9eb">Atlanta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18yLTItMS0xLTA_61848329-4bcb-4279-8605-e15c08e1c62a">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN18yLTMtMS0xLTA_a9f45296-0ca5-480b-9cde-898d53fd5382">30308</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN180LTEtMS0xLTA_d0bf0a01-b450-4398-be4c-aa087908fba5">(888)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6Y2MxZDQxMDRiNzFiNDBlZjllODExNWUzNTE4NzQ5MzcvdGFibGVyYW5nZTpjYzFkNDEwNGI3MWI0MGVmOWU4MTE1ZTM1MTg3NDkzN180LTItMS0xLTA_f04edf44-630c-45cc-8e87-b98ad04c0d1d">798-5802</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6M2IxM2YxMDViYzUyNDE3MDkyY2UzNGQ5MTM5ODQzMTAvdGFibGVyYW5nZTozYjEzZjEwNWJjNTI0MTcwOTJjZTM0ZDkxMzk4NDMxMF8wLTAtMS0xLTA_40d3bef0-3faf-4d80-b5e2-ea9399fd2f82">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6M2IxM2YxMDViYzUyNDE3MDkyY2UzNGQ5MTM5ODQzMTAvdGFibGVyYW5nZTozYjEzZjEwNWJjNTI0MTcwOTJjZTM0ZDkxMzk4NDMxMF8xLTAtMS0xLTA_3a1d4cd6-f3df-40cd-a8e2-062674fa6b5e">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6M2IxM2YxMDViYzUyNDE3MDkyY2UzNGQ5MTM5ODQzMTAvdGFibGVyYW5nZTozYjEzZjEwNWJjNTI0MTcwOTJjZTM0ZDkxMzk4NDMxMF8yLTAtMS0xLTA_904c7fd1-e9f9-4323-9a11-908003699584">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6M2IxM2YxMDViYzUyNDE3MDkyY2UzNGQ5MTM5ODQzMTAvdGFibGVyYW5nZTozYjEzZjEwNWJjNTI0MTcwOTJjZTM0ZDkxMzk4NDMxMF8zLTAtMS0xLTA_435a6cba-40f6-45a0-9f1f-90f47525f037">false</dei:PreCommencementIssuerTenderOffer>
    <cdlx:Titleof12bSecurity
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6NmI1NzI3MWYwMTlmNGNjOWJhNjQwZjEyMzEzZDhjNjMvdGFibGVyYW5nZTo2YjU3MjcxZjAxOWY0Y2M5YmE2NDBmMTIzMTNkOGM2M18xLTAtMS0xLTA_928bcb74-7bff-40d3-a7dd-029154ecd7fb">Common Stock</cdlx:Titleof12bSecurity>
    <dei:TradingSymbol
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6NmI1NzI3MWYwMTlmNGNjOWJhNjQwZjEyMzEzZDhjNjMvdGFibGVyYW5nZTo2YjU3MjcxZjAxOWY0Y2M5YmE2NDBmMTIzMTNkOGM2M18xLTEtMS0xLTA_799ef44c-7d06-4f80-a947-4fa6d4315ac8">CDLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6NmI1NzI3MWYwMTlmNGNjOWJhNjQwZjEyMzEzZDhjNjMvdGFibGVyYW5nZTo2YjU3MjcxZjAxOWY0Y2M5YmE2NDBmMTIzMTNkOGM2M18xLTItMS0xLTA_ed4d55d8-118f-4293-8fc2-d130c3d723ba">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302"
      id="id3VybDovL2RvY3MudjEvZG9jOjZlOTAzZTEzYWFkNTRlOTBiZGI1NzY0ODBlYjNkNmU0L3NlYzo2ZTkwM2UxM2FhZDU0ZTkwYmRiNTc2NDgwZWIzZDZlNF8xL2ZyYWc6NzQzOWRkZWY3ZTgzNDRkZGE3MGY0M2U3MTRiOWM5ZWIvdGFibGU6NTBmYTNiY2Q3OWViNGU2YWFiMWYwOGU1MDYyODU1M2QvdGFibGVyYW5nZTo1MGZhM2JjZDc5ZWI0ZTZhYWIxZjA4ZTUwNjI4NTUzZF8wLTEtMS0xLTA_66439c5f-49da-4588-a56e-f7e1e3ad474d">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140648774844712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 02, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  02,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CARDLYTICS,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0001666071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-3039436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">675 Ponce de Leon Avenue NE, Suite 6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Atlanta<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(888)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">798-5802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cdlx_Titleof12bSecurity', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Entity Registrant Name</a></td>
<td class="text">CDLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cdlx_Titleof12bSecurity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of 12(b) Security</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cdlx_Titleof12bSecurity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cdlx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>16
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
MN()E4@=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " "X@F52S!UI7^\    K @  $0
M@ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "X@F52F5R<(Q &
M  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( +B"95(]S$?#5@0  ,H0   8              " @0X(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "X@F52@ZFE ]0!
M   R!@  #0              @ &:#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( +B"95*7BKL<P    !,"   +              "  9D.  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( +B"95(<.&7J/P$  #P"   /              "
M 8(/  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "X@F52)!Z;HJT   #X
M 0  &@              @ 'N$   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " "X@F5299!YDAD!  #/ P  $P              @ '3
L$0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   =$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cdlx-20210302.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cardlytics.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cdlx-20210302.htm">cdlx-20210302.htm</File>
    <File>a231cooleyllpconsent_2021x.htm</File>
    <File>a51cooleyllpopinion_2021x8k.htm</File>
    <File>cdlx-20210302.xsd</File>
    <File>cdlx-20210302_cal.xml</File>
    <File>cdlx-20210302_def.xml</File>
    <File>cdlx-20210302_lab.xml</File>
    <File>cdlx-20210302_pre.xml</File>
    <File>cdlx_exx11xunderwritingxag.htm</File>
    <File>cdlx_exx991x0301pressrelea.htm</File>
    <File>cdlx_exx992x0302pressrelea.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cdlx-20210302_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cdlx-20210302.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 2,
   "dts": {
    "calculationLink": {
     "local": [
      "cdlx-20210302_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cdlx-20210302_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cdlx-20210302.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cdlx-20210302_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cdlx-20210302_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cdlx-20210302.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 27,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 1,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cdlx",
   "nsuri": "http://www.cardlytics.com/20210302",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cdlx-20210302.htm",
      "contextRef": "id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.cardlytics.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cdlx-20210302.htm",
      "contextRef": "id2bbef42969a49aba50ce9f7a990f89f_D20210302-20210302",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "cdlx_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document and Entity Information [Abstract]",
        "label": "Document And Entity Information [Abstract]",
        "terseLabel": "Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.cardlytics.com/20210302",
     "xbrltype": "stringItemType"
    },
    "cdlx_Titleof12bSecurity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Titleof12bSecurity",
     "nsuri": "http://www.cardlytics.com/20210302",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cardlytics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r4": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r5": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001666071-21-000035-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001666071-21-000035-xbrl.zip
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M!IC@S:*^TL4T*[&@P(^MC=#*98Y-M.!A:IRE-/2(\V@C+&]*R]Z78AXU0ET
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M,C R,7@X:RYH=&WM6FES&[D1_9Y?@9637;F*]Z&#DE5E';MQ1995EA)5/J7
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M]DYW]RW;[^\V>WWHQR;W'@_H<1* :*&T>.A[K?(:/W0+G]P=_0=02P,$%
M  @ N()E4F=4^)GK&@  UK$  !$   !C9&QX+3(P,C$P,S R+FAT;>U=ZU?B
MR+;_?OZ*7.;<<[K7,I#W@^[V+EO084; 5FP'O_2JI"H0# F3! '_^KNK*H&
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MMN19ML=PQIJ<MUW**R),A^3??$R_>SZ)!4806:N@#QM_+HO$ZLO[^4_+M8^
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MP#BSI#!S$.F3>+'L:0P5Q0(*9_DS#\ 33>B+-/SV:4(]J3X:O,^W]L;2U<=
M5<E??-+E++96MK7M5LD\/@\?$._NFLYHM#U\#P!B@7 1^E21"LWS1^/WQ^2
MG"@*' 1H3$$HBA[+9>RG( %TQF<<9A,>R1MV6YI* ]KH@MORU>_>7LS #5&;
MM>M95P&7Y1C<E4Y3;]>^W#8[!ZNG/=QV!_7;JP&X+9=_#%H=<%LZ[J3=^6,
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M$.#+V3T?I(GCRZL7Z\O#G^'IM5<O_@M02P,$%     @ N()E4O"N<.F%3
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MOX7A0]4^GR>K?!L)/)YP,(26MJ:P5-24]CHG8O%%@QU^ _4+PQ^PU(ZPUX3
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MR^WPN()<(8?C\98OBEVJ9+%D>I(C[J?[#$P.1^@1.-54EAUQ8(D"2.%SW)*
M@^+G2K5&'5=KX$<%<7_8)M<C+B@&2/$^P!OB^@ /HA&6 1I,5F+8A_)8+&%
M&4\PHT*=1T\3BQ.!2,QD5D)0B*/4T=0B(R7 Y@()MH<(BR$PI/ 0S!*+5H5W
MP#&6" U1HTH9MPR0:^"JK'J#B\UWQSPV;C"N!SAR0*;FX_%H O S0YB+#WCL
M 9')ZR;Y;5XRWL)S8'5 ".52"=RH3Z=%59206"M3<6CEADV)B8@\/TG&=S 5
MQCA?2F/BS7H0B8 20IQ%(M"U;B*J89")YD@X*($);%4P8B9*N7Q5).Z#*;%0
M")$A+CP"J_'6\JCG#9/T.E0'$GDZL@'O-\5Y-&X Y=A"BIA7); ) B%),"R
M[4*^10;$J8 43;BP#> 5QQ-@&(9!!X*H2&:RQ89*RQVL6*#@&,(VIY&EXUJU
MEE",YM0HM0X/S\CT^1(0 4C(((J>C#"Q#>01J51DB=E)2LA-!)T5IDBQW-/A
MI\(!2\@I<Y0!"J420XRKTR(2LD*EHF 6 3%D"IF=31<JR3Q?(JACJ\0FLC%,
M$MM LUR8$ )1893,\5&,3(00!61R'9U!8.%5,EVY'4:B+A[>[K*(M6$X+@G$
MU3$5EPVIS#J*R85JI5$FVQ@D"U1L6=0FX7&LL TO2XB! &;8#"7/Z!53=6A
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M0<S?8"D9*@Y8O.65E)0K8\4A%P\;O#.@X%,0?QR/I;$L(9?I9(<A,R#E0R%
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MTR#S&=A.N#RF\.ALK]X3<YK5',@I,O/5U+C&[#8R6%&%S1T' (\M@O !CXM
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M=9)%E>DW4^S9WK4YCHE=V:Q]MIJ;/@N4[U8?3IOZ=LU&C)?<9&29M,.9S13
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M,359"2;'91%L0N-UE)DU;V%O@Q2JS K),GMU:Q7$+B#S![9.M&CP-$WY9Y:
M,D1#VS=0STC#ABASFSJ32/.#7N%/%.'H*-MNP%.LK[(E46W!G^2*R6%8J4FD
M1R%0J.+IW9"V(Y<]R7+<X)I:1_!X^!%2+=I9O9NRS3E1&N N,0_#/A>U&"0R
M-'1&^N8MVQQ[YSK\MO,B]KTQ>NY6QKXPC==JN*MTPG$@.L*5:XH9VL4'FN"B
M_K!9OS+O].B$6H>^<RTDH_='_W7(-71@S+GNU+TW4;W/>#=KLW8NJ!*JA[*Z
M3 K!T@[KABU502!QQ!CTND>2MO*VY \22W%'%6$"-(.SD53[K)7Z&N2S%$6P
M85O*[S5[5IM-"[\_-#I+ZKUNI\FDV&ZK_V#-@LF8/U2S# 4L9GQHOL%)BRE,
MIVE[!I'1C6@;-[7 U_/LDQ*>IN!J*LE_VC4OOCI"*$#TSYP(XM<2-SNV2Q&2
M;$FE'H'3B4DO/!:=4RE%QW(LMSY">F/PO/2YN&=P_J=-OK)-+,)0 #;CY*!\
MCG%B\:=KQO;X]8BC15DUEY277!*D#21.EH+<28MINYA4F(>+T:O.%O@R7DZ$
MS10.]F1WH9;^'_/^?JBP&]H1')O9$,KRR3[#$EUG99[83,<2C=HE!<#,@\F[
MK;M3Y72%ISEW;V$_17 D)I;1C2/!4"3:%7[.UTZH:_L ?-M.N,0Q%9\7!2+\
MWZ4@_1O\$G7F/CTY^D^7^M" /N(BTFE*S8O.N-GJ2;P&&N"Z49QJ-PH*N#P[
M="%_O@K!Z$G QC9P(Y?6]T\B5P#E4VYFCH>O#&O/4V\3K+=$!F@ AHV-?2N&
M^[AKAJOKMDU+>O=97,M&,2*_1R5'YSJ.,I"1:!WH-O3U[!T7QL[;1<'5<G@G
MM2$'\8_K6?=V*4R'7JWM1(*M<109HMJY@\BD!B') 'G$.T^E9PB)?HN![G:]
MM'_#5%=UK9E;T\42I?ABF9>KU) J&[$\Q8F!9%WF6!_5X;3XN@O:@72SUI0&
M=G@0RN(:C5S<XMJC4E&W+SG2\2U'=R@*XFN>41_RWVQJL#^ N*!UYL9GJ.)M
M!WL[+2PZ9DM=;$:P=V&*?->D_;D<([<[3B3<=>&S%4^C9C;Z-7! -"3LN3ZZ
MM2A[=DX6NWU.<*V?4W!@:6_U+O0\_W UVBQ)SD1 DM5K-3LN9E&_JE*E%: >
M2 .-@-;H6<-K8R3UV+%=^R I4=*&/8J!%*-<H">]-M)*-32@+];JBC 'X)8A
MK'S*N *]T];Z*\EZ%\)(ZMXF&05XDV0=PB>OI7S!C5U*EW1:D-9'/2<0L'HM
MS*>DOQC\C:^MD J=+?F0/C=^)GVBW#6L==P;ADTX$%[XGL7+_:]X/N1P*5 2
M^P]229_?'.UV+4?*;#LW>('W^E8CTI(C"&IQM0:W:I;GWF?:[S/M7Z WBYW3
MF^"/B:#\OVH$PRU\GLZ3-A>XY860JMVQYGQCN@VI M(N0R; !J(38UI=JYXP
M,R 0J,/H9'7$*14OZ6W&! &?4K[ H*8,JZAH150.27Z:E0Q\>T(>J:PD879<
MTMIXJ!B4NDZ+A&O$'&8L%,0$]2FYZQ=*2NS9U!)[I0MGSK!>#!4%MA:,H[Q,
M*.O#9#3V=0B&U3R+4V[N[PQ)4X'J.X=GP@C"C<9*"O7;OTS*EG%-[AL&MH4Z
MN2%=JP+W(,R;:4S!N^UXR%YYP>X!94'D@)2)'$O"G+J(?\RAO)6!V+E07[Q-
MT)_ >0<7_5-#S;^2FYC4:$M/:W-ZIL;TXNBW=G;)JTU%GC$I=F;VFV*D6AZ3
M5""X*FP/1HU]L=_\)1R&JL#O(JM0.5NY!V,/,?Y%,L/>:ZR4L7[Y$JZKZ4#E
MDFHQ?9X@=/P1L$%0>X7IPFO$6+BZ>]HQDV^+=?,H#*'8^%YV]"<[[!<8*EJ-
M;YE;SJ^^:6P7L7]%&^%H$PV Q%N!73/7F:.(YK9>POKV7YDK8_VZ!E.G[J-O
MR(>FK#ZA]>V-A6# ^ Q#W[-9TT8F-!K0^P<__:T\V=<+8/+%LTYUO +?Q<X
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M3W^,/I0M:+GH]>NW"/@OF8\9H]C$6^SZ8PVU9=HJWL[M[#.S$HPBI C\LIW
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M=>'Y-T@HY%AS:K=+ZZ00N1''[X^MZ[J)]Y^\(UH[Z_^<,P3@0M%"<__LYY@
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ML+X#YG/!P]<5\KECNT2.,V68M"'2^BU'#RKGGWQK"0/AST*"X*P/B@KD*1(
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ML8&CY<AVZ@83$XZ;TE0MD/?01<F9P<HQM"-"FJJL]G7$]HN^2D]WV)8#4 '
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M!ZJR66(VY:O<,N*26>(4Y@0@0*[PL#&K)6XS4&.V<O62"79 &IH90'JGX$(
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M)GQEMDX75SL<%'-52LUO/%18O\N6RP#! C73&;*H3#NY"'W[Z=70#2@'>HF
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MA$ 3JEIH=OXH3XO+YLJR;ACDCVW>=4MB8?\QNI[\033^1A(J(^QYCI(7>2A
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M+S"=/#466:2[S>NE4"D:,X*".8>5Q#D*W.P!WYWW0(QG5Y!.?479>/WB$DS
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M]+AAZ RFP#) *)1 HH]H6EA'\WCL2EB!7)D&8,+,+D]U*:.Y*]'^?&B]T>F
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M/SAH]?J[^UL"2KO?DP[;59@[X>]%^"]7SOX-4$L! A0#%     @ N()E4N[
MH83C"   NR<  !X              ( !     &$R,S%C;V]L97EL;'!C;VYS
M96YT7S(P,C%X+FAT;5!+ 0(4 Q0    ( +B"95+W4Y!YY0@  ,TG   ?
M          "  1\)  !A-3%C;V]L97EL;'!O<&EN:6]N7S(P,C%X.&LN:'1M
M4$L! A0#%     @ N()E4F=4^)GK&@  UK$  !$              ( !01(
M &-D;'@M,C R,3 S,#(N:'1M4$L! A0#%     @ N()E4L)#038I P  H L
M !$              ( !6RT  &-D;'@M,C R,3 S,#(N>'-D4$L! A0#%
M  @ N()E4DK$"<^/ 0  #P,  !4              ( !LS   &-D;'@M,C R
M,3 S,#)?8V%L+GAM;%!+ 0(4 Q0    ( +B"95*]LC0A^ <  +8X   5
M          "  74R  !C9&QX+3(P,C$P,S R7V1E9BYX;6Q02P$"% ,4
M" "X@F52\*YPZ85,  !6:   %               @ &@.@  8V1L>"TR,#(Q
M,#,P,E]G,2YJ<&=02P$"% ,4    " "X@F52."$\:B0,  "X<   %0
M        @ %7AP  8V1L>"TR,#(Q,#,P,E]L86(N>&UL4$L! A0#%     @
MN()E4D7B9YZ0!P  ^#H  !4              ( !KI,  &-D;'@M,C R,3 S
M,#)?<')E+GAM;%!+ 0(4 Q0    ( +B"95**\,9-4(X  ,6/ P >
M      "  7&;  !C9&QX7V5X>#$Q>'5N9&5R=W)I=&EN9WAA9RYH=&U02P$"
M% ,4    " "X@F52,U#*.?0)  !"(@  '@              @ ']*0$ 8V1L
M>%]E>'@Y.3%X,#,P,7!R97-S<F5L96$N:'1M4$L! A0#%     @ N()E4J8K
MAG!C"@  %",  !X              ( !+30! &-D;'A?97AX.3DR># S,#)P
C<F5S<W)E;&5A+FAT;5!+!08     #  , $D#  #,/@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
